| Year |
Citation |
Score |
| 2016 |
Regoli D, Gobeil F. Kinins and peptide receptors. Biological Chemistry. 397: 297-304. PMID 26408609 DOI: 10.1515/Hsz-2015-0240 |
0.413 |
|
| 2015 |
Savard M, Côté J, Tremblay L, Neugebauer W, Regoli D, Gariépy S, Hébert N, Gobeil F. Safety and pharmacokinetics of a kinin B1 receptor peptide agonist produced with different counter-ions. Biological Chemistry. PMID 26565554 DOI: 10.1515/Hsz-2015-0246 |
0.39 |
|
| 2015 |
Regoli D, Gobeil F. Critical insights into the beneficial and protective actions of the kallikrein-kinin system. Vascular Pharmacology. 64: 1-10. PMID 25579779 DOI: 10.1016/J.Vph.2014.12.003 |
0.321 |
|
| 2014 |
Gobeil F, Sirois P, Regoli D. Preclinical pharmacology, metabolic stability, pharmacokinetics and toxicology of the peptidic kinin B1 receptor antagonist R-954. Peptides. 52: 82-9. PMID 24361511 DOI: 10.1016/J.Peptides.2013.12.009 |
0.412 |
|
| 2013 |
Rodi D, Buzzi A, Barbieri M, Zucchini S, Verlengia G, Binaschi A, Regoli D, Boschi A, Ongali B, Couture R, Simonato M. Bradykinin B₂ receptors increase hippocampal excitability and susceptibility to seizures in mice. Neuroscience. 248: 392-402. PMID 23811399 DOI: 10.1016/J.Neuroscience.2013.06.038 |
0.447 |
|
| 2012 |
Rizzi A, Campi B, Camarda V, Molinari S, Cantoreggi S, Regoli D, Pietra C, Calo' G. In vitro and in vivo pharmacological characterization of the novel NK₁ receptor selective antagonist Netupitant. Peptides. 37: 86-97. PMID 22732666 DOI: 10.1016/J.Peptides.2012.06.010 |
0.51 |
|
| 2012 |
Regoli D, Plante GE, Gobeil F. Impact of kinins in the treatment of cardiovascular diseases. Pharmacology & Therapeutics. 135: 94-111. PMID 22537664 DOI: 10.1016/J.Pharmthera.2012.04.002 |
0.344 |
|
| 2011 |
Calo' G, Rizzi A, Cifani C, Micioni Di Bonaventura MV, Regoli D, Massi M, Salvadori S, Lambert DG, Guerrini R. UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor. Cns Neuroscience & Therapeutics. 17: 178-98. PMID 20497197 DOI: 10.1111/J.1755-5949.2009.00107.X |
0.54 |
|
| 2010 |
Guerrini R, Salvadori S, Rizzi A, Regoli D, Calo' G. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. Medicinal Research Reviews. 30: 751-77. PMID 19824051 DOI: 10.1002/Med.20180 |
0.363 |
|
| 2009 |
Bossi F, Fischetti F, Regoli D, Durigutto P, Frossi B, Gobeil F, Ghebrehiwet B, Peerschke EI, Cicardi M, Tedesco F. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. The Journal of Allergy and Clinical Immunology. 124: 1303-10.e4. PMID 19796797 DOI: 10.1016/J.Jaci.2009.08.007 |
0.459 |
|
| 2009 |
Trapella C, Fischetti C, Pela' M, Lazzari I, Guerrini R, Calo' G, Rizzi A, Camarda V, Lambert DG, McDonald J, Regoli D, Salvadori S. Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. Bioorganic & Medicinal Chemistry. 17: 5080-95. PMID 19527931 DOI: 10.1016/J.Bmc.2009.05.068 |
0.466 |
|
| 2009 |
Guerrini R, Camarda V, Trapella C, Caló G, Rizzi A, Ruzza C, Fiorini S, Marzola E, Reinscheid RK, Regoli D, Salvadori S. Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. Journal of Medicinal Chemistry. 52: 4068-71. PMID 19473027 DOI: 10.1021/Jm900604G |
0.404 |
|
| 2009 |
Batuwangala M, Camarda V, McDonald J, Marzola E, Lambert DG, Ng LL, Calo' G, Regoli D, Trapella C, Guerrini R, Salvadori S. Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. Peptides. 30: 1130-6. PMID 19463746 DOI: 10.1016/J.Peptides.2009.02.003 |
0.463 |
|
| 2009 |
Fischetti C, Camarda V, Rizzi A, Pelà M, Trapella C, Guerrini R, McDonald J, Lambert DG, Salvadori S, Regoli D, Calo' G. Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. European Journal of Pharmacology. 614: 50-7. PMID 19445927 DOI: 10.1016/J.Ejphar.2009.04.054 |
0.508 |
|
| 2009 |
Camarda V, Fischetti C, Anzellotti N, Molinari P, Ambrosio C, Kostenis E, Regoli D, Trapella C, Guerrini R, Severo S, Calo G. Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein G alpha qi5. Naunyn-Schmiedeberg's Archives of Pharmacology. 379: 599-607. PMID 19183962 DOI: 10.1007/S00210-009-0396-X |
0.492 |
|
| 2009 |
Guerrini R, Camarda V, Trapella C, Calò G, Rizzi A, Ruzza C, Fiorini S, Marzola E, Reinscheid RK, Regoli D, Salvadori S. Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists. Journal of Medicinal Chemistry. 52: 524-9. PMID 19113861 DOI: 10.1021/Jm8012294 |
0.426 |
|
| 2009 |
Pietrovski EF, Otuki MF, Regoli D, Bader M, Pesquero JB, Cabrini DA, Zampronio AR. The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammation. Regulatory Peptides. 152: 67-72. PMID 18977249 DOI: 10.1016/J.Regpep.2008.10.005 |
0.526 |
|
| 2009 |
Camarda V, Rizzi A, Ruzza C, Zucchini S, Marzola G, Marzola E, Guerrini R, Salvadori S, Reinscheid RK, Regoli D, Calò G. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S. The Journal of Pharmacology and Experimental Therapeutics. 328: 549-55. PMID 18971372 DOI: 10.1124/Jpet.108.143867 |
0.351 |
|
| 2008 |
Camarda V, Trapella C, Calo' G, Guerrini R, Rizzi A, Ruzza C, Fiorini S, Marzola E, Reinscheid RK, Regoli D, Salvadori S. Structure-activity study at positions 3 and 4 of human neuropeptide S. Bioorganic & Medicinal Chemistry. 16: 8841-5. PMID 18793857 DOI: 10.1016/J.Bmc.2008.08.073 |
0.361 |
|
| 2008 |
Marceau F, Regoli D. Therapeutic options in inflammatory bowel disease: experimental evidence of a beneficial effect of kinin B1 receptor blockade. British Journal of Pharmacology. 154: 1163-5. PMID 18536746 DOI: 10.1038/Bjp.2008.233 |
0.463 |
|
| 2008 |
Rizzi A, Vergura R, Marzola G, Ruzza C, Guerrini R, Salvadori S, Regoli D, Calo G. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. British Journal of Pharmacology. 154: 471-9. PMID 18376418 DOI: 10.1038/Bjp.2008.96 |
0.338 |
|
| 2008 |
Camarda V, Trapella C, Calo G, Guerrini R, Rizzi A, Ruzza C, Fiorini S, Marzola E, Reinscheid RK, Regoli D, Salvadori S. Synthesis and biological activity of human neuropeptide S analogues modified in position 2. Journal of Medicinal Chemistry. 51: 655-8. PMID 18181564 DOI: 10.1021/Jm701204N |
0.426 |
|
| 2008 |
Vergura R, Balboni G, Spagnolo B, Gavioli E, Lambert DG, McDonald J, Trapella C, Lazarus LH, Regoli D, Guerrini R, Salvadori S, Caló G. Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides. 29: 93-103. PMID 18069089 DOI: 10.1016/J.Peptides.2007.10.012 |
0.504 |
|
| 2008 |
Marzola E, Camarda V, Batuwangala M, Lambert DG, Calo' G, Guerrini R, Trapella C, Regoli D, Tomatis R, Salvadori S. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11). Peptides. 29: 674-9. PMID 17822806 DOI: 10.1016/J.Peptides.2007.07.025 |
0.369 |
|
| 2007 |
Lungu C, Dias JP, França CE, Ongali B, Regoli D, Moldovan F, Couture R. Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance. Neuropeptides. 41: 375-87. PMID 17988733 DOI: 10.1016/J.Npep.2007.09.005 |
0.325 |
|
| 2007 |
Tancredi T, Guerrini R, Marzola E, Trapella C, Calo G, Regoli D, Reinscheid RK, Camarda V, Salvadori S, Temussi PA. Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor. Journal of Medicinal Chemistry. 50: 4501-8. PMID 17696420 DOI: 10.1021/Jm0706822 |
0.427 |
|
| 2007 |
Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, Calo G. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Peptides. 28: 1240-51. PMID 17532097 DOI: 10.1016/J.Peptides.2007.04.020 |
0.468 |
|
| 2007 |
Gavioli EC, Rizzi A, Marzola G, Zucchini S, Regoli D, Calo' G. Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides. 28: 1229-39. PMID 17499882 DOI: 10.1016/J.Peptides.2007.04.012 |
0.404 |
|
| 2007 |
Arduin M, Spagnolo B, Calò G, Guerrini R, Carrà G, Fischetti C, Trapella C, Marzola E, McDonald J, Lambert DG, Regoli D, Salvadori S. Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids. Bioorganic & Medicinal Chemistry. 15: 4434-43. PMID 17490886 DOI: 10.1016/J.Bmc.2007.04.026 |
0.404 |
|
| 2007 |
Spagnolo B, Carrà G, Fantin M, Fischetti C, Hebbes C, McDonald J, Barnes TA, Rizzi A, Trapella C, Fanton G, Morari M, Lambert DG, Regoli D, Calò G. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies. The Journal of Pharmacology and Experimental Therapeutics. 321: 961-7. PMID 17329552 DOI: 10.1124/Jpet.106.116764 |
0.418 |
|
| 2007 |
Rizzi A, Gavioli EC, Marzola G, Spagnolo B, Zucchini S, Ciccocioppo R, Trapella C, Regoli D, Calò G. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies. The Journal of Pharmacology and Experimental Therapeutics. 321: 968-74. PMID 17329551 DOI: 10.1124/Jpet.106.116780 |
0.454 |
|
| 2007 |
Nazzaro C, Rizzi A, Salvadori S, Guerrini R, Regoli D, Zeilhofer HU, Calo G. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice. Peptides. 28: 663-9. PMID 17161885 DOI: 10.1016/J.Peptides.2006.11.004 |
0.417 |
|
| 2007 |
Zhuo JL, Carretero OA, Peng H, Li XC, Regoli D, Neugebauer W, Rhaleb NE. Characterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblasts. American Journal of Physiology. Heart and Circulatory Physiology. 292: H984-93. PMID 17028162 DOI: 10.1152/Ajpheart.00776.2006 |
0.41 |
|
| 2006 |
Vergura R, Valenti E, Hebbes CP, Gavioli EC, Spagnolo B, McDonald J, Lambert DG, Balboni G, Salvadori S, Regoli D, Calo' G. Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies. Peptides. 27: 3322-30. PMID 16963157 DOI: 10.1016/J.Peptides.2006.07.015 |
0.494 |
|
| 2006 |
Roth AL, Marzola E, Rizzi A, Arduin M, Trapella C, Corti C, Vergura R, Martinelli P, Salvadori S, Regoli D, Corsi M, Cavanni P, Caló G, Guerrini R. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation. The Journal of Biological Chemistry. 281: 20809-16. PMID 16720571 DOI: 10.1074/Jbc.M601846200 |
0.47 |
|
| 2006 |
Rizzi A, Nazzaro C, Marzola GG, Zucchini S, Trapella C, Guerrini R, Zeilhofer HU, Regoli D, Calo' G. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences. Pain. 124: 100-8. PMID 16697109 DOI: 10.1016/J.Pain.2006.03.021 |
0.443 |
|
| 2006 |
Camarda V, Spagnol M, Song W, Vergura R, Roth AL, Thompson JP, Rowbotham DJ, Guerrini R, Marzola E, Salvadori S, Cavanni P, Regoli D, Douglas SA, Lambert DG, Calò G. In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803). British Journal of Pharmacology. 147: 92-100. PMID 16273120 DOI: 10.1038/Sj.Bjp.0706438 |
0.42 |
|
| 2006 |
Trapella C, Guerrini R, Piccagli L, Calo' G, Carra' G, Spagnolo B, Rubini S, Fanton G, Hebbes C, McDonald J, Lambert DG, Regoli D, Salvadori S. Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist. Bioorganic & Medicinal Chemistry. 14: 692-704. PMID 16202610 DOI: 10.1016/J.Bmc.2005.08.049 |
0.446 |
|
| 2006 |
Vergura R, Balboni G, Spagnolo B, Gavioli EC, Lambert D, Mcdonald J, Trapella C, Regoli D, Salvadori S, Calo G. Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opioid receptor agonist European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)80106-9 |
0.465 |
|
| 2005 |
Basso M, Risse PA, Naline E, Calo G, Guerrini R, Regoli D, Advenier C. Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation. Peptides. 26: 1492-6. PMID 16042989 DOI: 10.1016/J.Peptides.2005.03.016 |
0.428 |
|
| 2005 |
Gendron G, Gobeil F, Bélanger S, Gagnon S, Regoli D, D'Orléans-Juste P. Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats. Peptides. 26: 1468-74. PMID 16042987 DOI: 10.1016/J.Peptides.2005.03.012 |
0.412 |
|
| 2005 |
Blais PA, Côté J, Morin J, Larouche A, Gendron G, Fortier A, Regoli D, Neugebauer W, Gobeil F. Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative study. Peptides. 26: 1317-22. PMID 16042973 DOI: 10.1016/J.Peptides.2005.03.026 |
0.423 |
|
| 2005 |
Calo G, Guerrini R, Rizzi A, Salvadori S, Burmeister M, Kapusta DR, Lambert DG, Regoli D. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. Cns Drug Reviews. 11: 97-112. PMID 16007234 DOI: 10.1111/J.1527-3458.2005.Tb00264.X |
0.517 |
|
| 2005 |
Carra' G, Calo' G, Spagnolo B, Guerrini R, Arduin M, Marzola E, Trapella C, Regoli D, Salvadori S. Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2. The Journal of Peptide Research : Official Journal of the American Peptide Society. 66: 39-47. PMID 15946194 DOI: 10.1111/J.1399-3011.2005.00272.X |
0.479 |
|
| 2005 |
Bkaily G, El-Bizri N, Nader M, Hazzouri KM, Riopel J, Jacques D, Regoli D, D'Orleans-Juste P, Gobeil F, Avedanian L. Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT1 and AT2 receptors. Peptides. 26: 1418-26. PMID 15876474 DOI: 10.1016/J.Peptides.2005.03.051 |
0.339 |
|
| 2005 |
Guerrini R, Caló G, Lambert DG, Carrá G, Arduin M, Barnes TA, McDonald J, Rizzi D, Trapella C, Marzola E, Rowbotham DJ, Regoli D, Salvadori S. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands. Journal of Medicinal Chemistry. 48: 1421-7. PMID 15743186 DOI: 10.1021/Jm040106V |
0.445 |
|
| 2005 |
Tancredi T, Carrà G, Guerrini R, Arduin M, Calò G, Regoli D, Salvadori S, Temussi PA. The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ. Chemistry (Weinheim An Der Bergstrasse, Germany). 11: 2061-70. PMID 15712334 DOI: 10.1002/Chem.200401095 |
0.409 |
|
| 2005 |
Guerrini R, Camarda V, Marzola E, Arduin M, Calo G, Spagnol M, Rizzi A, Salvadori S, Regoli D. Structure-activity relationship study on human urotensin II. Journal of Peptide Science : An Official Publication of the European Peptide Society. 11: 85-90. PMID 15635628 DOI: 10.1002/Psc.590 |
0.495 |
|
| 2005 |
Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, et al. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor. The Journal of Pharmacology and Experimental Therapeutics. 312: 1114-23. PMID 15509719 DOI: 10.1124/Jpet.104.077339 |
0.489 |
|
| 2005 |
Guerrini R, Carra' G, Calo' G, Trapella C, Marzola E, Rizzi D, Regoli D, Salvadori S. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity. The Journal of Peptide Research : Official Journal of the American Peptide Society. 63: 477-84. PMID 15175020 DOI: 10.1111/J.1399-3011.2004.00157.X |
0.428 |
|
| 2004 |
Bossi F, Fischetti F, Pellis V, Bulla R, Ferrero E, Mollnes TE, Regoli D, Tedesco F. Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. Journal of Immunology (Baltimore, Md. : 1950). 173: 6921-7. PMID 15557188 DOI: 10.4049/Jimmunol.173.11.6921 |
0.369 |
|
| 2004 |
Gendron G, Gobeil F, Morin J, D'Orléans-Juste P, Regoli D. Contractile responses of aortae from WKY and SHR to vasoconstrictors. Clinical and Experimental Hypertension (New York, N.Y. : 1993). 26: 511-23. PMID 15554454 DOI: 10.1081/Ceh-200031826 |
0.413 |
|
| 2004 |
Vergura R, Camarda V, Rizzi A, Spagnol M, Guerrini R, Calo' G, Salvadori S, Regoli D. Urotensin II stimulates plasma extravasation in mice via UT receptor activation. Naunyn-Schmiedeberg's Archives of Pharmacology. 370: 347-52. PMID 15526105 DOI: 10.1007/S00210-004-0991-9 |
0.417 |
|
| 2004 |
Marceau F, Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nature Reviews. Drug Discovery. 3: 845-52. PMID 15459675 DOI: 10.1038/Nrd1522 |
0.515 |
|
| 2004 |
Camarda V, Song W, Marzola E, Spagnol M, Guerrini R, Salvadori S, Regoli D, Thompson JP, Rowbotham DJ, Behm DJ, Douglas SA, Calo' G, Lambert DG. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors. European Journal of Pharmacology. 498: 83-6. PMID 15363979 DOI: 10.1016/J.Ejphar.2004.07.089 |
0.514 |
|
| 2004 |
Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo' G. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 369: 547-53. PMID 15197534 DOI: 10.1007/S00210-004-0939-0 |
0.406 |
|
| 2004 |
Gendron G, Simard B, Gobeil F, Sirois P, D'Orléans-Juste P, Regoli D. Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats. Canadian Journal of Physiology and Pharmacology. 82: 16-21. PMID 15052301 DOI: 10.1139/Y03-122 |
0.378 |
|
| 2003 |
Gavioli EC, Marzola G, Guerrini R, Bertorelli R, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo G. Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. The European Journal of Neuroscience. 17: 1987-90. PMID 12752799 DOI: 10.1046/J.1460-9568.2003.02603.X |
0.483 |
|
| 2003 |
Ongali B, Campos MM, Bregola G, Rodi D, Regoli D, Thibault G, Simonato M, Couture R. Autoradiographic analysis of rat brain kinin B1 and B2 receptors: normal distribution and alterations induced by epilepsy. The Journal of Comparative Neurology. 461: 506-19. PMID 12746865 DOI: 10.1002/Cne.10706 |
0.48 |
|
| 2003 |
El-Bizri N, Bkaily G, Wang S, Jacques D, Regoli D, D'Orléans-Juste P, Sukarieh R. Bradykinin induced a positive chronotropic effect via stimulation of T- and L-type calcium currents in heart cells. Canadian Journal of Physiology and Pharmacology. 81: 247-58. PMID 12733823 DOI: 10.1139/Y03-045 |
0.379 |
|
| 2003 |
Fortin JP, Gobeil F, Adam A, Regoli D, Marceau F. Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor? American Journal of Physiology. Heart and Circulatory Physiology. 285: H277-82. PMID 12649080 DOI: 10.1152/Ajpheart.01124.2002 |
0.523 |
|
| 2003 |
Ongali B, Buck Hde S, Cloutier F, Legault F, Regoli D, Lambert C, Thibault G, Couture R. Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord. American Journal of Physiology. Heart and Circulatory Physiology. 284: H1949-58. PMID 12586640 DOI: 10.1152/Ajpheart.01113.2002 |
0.48 |
|
| 2003 |
Guerrini R, Rizzi D, Zucchini M, Tomatis R, Regoli D, Calo' G, Salvadori S. Nociceptin/Orphanin FQ(1-13)NH2 analogues modified in the Phe1-Gly2 peptide bond. Bioorganic & Medicinal Chemistry Letters. 13: 365-8. PMID 12565930 DOI: 10.1016/S0960-894X(02)01004-1 |
0.397 |
|
| 2003 |
Vianna RM, Ongali B, Regoli D, Calixto JB, Couture R. Up-regulation of kinin B1 receptor in the lung of streptozotocin-diabetic rat: autoradiographic and functional evidence. British Journal of Pharmacology. 138: 13-22. PMID 12522068 DOI: 10.1038/Sj.Bjp.0704999 |
0.446 |
|
| 2002 |
Farmer PJ, Girardot D, Lepage A, Regoli D, Sirois P. Inhibition of prostaglandin G/H synthase unveils a potent effect of platelet activating factor on the permeability of bovine aortic endothelial cells to albumin. Inflammation. 26: 253-8. PMID 12546134 DOI: 10.1023/A:1021477316559 |
0.332 |
|
| 2002 |
Rizzi A, Rizzi D, Marzola G, Regoli D, Larsen BD, Petersen JS, Calo G. Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: In vitro and in vivo studies in mice British Journal of Pharmacology. 137: 369-374. PMID 12237257 DOI: 10.1038/Sj.Bjp.0704894 |
0.501 |
|
| 2002 |
Camarda V, Guerrini R, Kostenis E, Rizzi A, Calò G, Hattenberger A, Zucchini M, Salvadori S, Regoli D. A new ligand for the urotensin II receptor. British Journal of Pharmacology. 137: 311-4. PMID 12237249 DOI: 10.1038/Sj.Bjp.0704895 |
0.494 |
|
| 2002 |
Rizzi A, Salis MB, Ciccocioppo R, Marzola G, Bigoni R, Guerrini R, Massi M, Madeddu P, Salvadori S, Regoli D, Calo' G. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies. Naunyn-Schmiedeberg's Archives of Pharmacology. 365: 450-6. PMID 12070758 DOI: 10.1007/S00210-002-0549-7 |
0.422 |
|
| 2002 |
Bigoni R, Rizzi D, Rizzi A, Camarda V, Guerrini R, Lambert DG, Hashiba E, Berger H, Salvadori S, Regoli D, Calo' G. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies. Naunyn-Schmiedeberg's Archives of Pharmacology. 365: 442-9. PMID 12070757 DOI: 10.1007/S00210-002-0548-8 |
0.511 |
|
| 2002 |
Bigoni R, Caò G, Rizzi A, Okawa H, Regoli D, Smart D, Lambert DG. Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors. Canadian Journal of Physiology and Pharmacology. 80: 407-12. PMID 12056546 DOI: 10.1139/Y02-040 |
0.328 |
|
| 2002 |
Camarda V, Rizzi A, Calo G, Guerrini R, Salvadori S, Regoli D. Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sciences. 71: 363-70. PMID 12044836 DOI: 10.1016/S0024-3205(02)01682-X |
0.503 |
|
| 2002 |
Neugebauer W, Blais PA, Hallé S, Filteau C, Regoli D, Gobeil F. Kinin B1 receptor antagonists with multi-enzymatic resistance properties. Canadian Journal of Physiology and Pharmacology. 80: 287-92. PMID 12025963 DOI: 10.1139/Y02-053 |
0.444 |
|
| 2002 |
Camarda V, Rizzi A, Calo G, Wirth K, Regoli D. Pharmacological characterisation of novel kinin B2 receptor ligands. Canadian Journal of Physiology and Pharmacology. 80: 281-6. PMID 12025962 DOI: 10.1139/Y02-037 |
0.45 |
|
| 2002 |
Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. British Journal of Pharmacology. 136: 303-11. PMID 12010780 DOI: 10.1038/Sj.Bjp.0704706 |
0.554 |
|
| 2002 |
Gobeil F, Hallé S, Blais PA, Regoli D. Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin. Canadian Journal of Physiology and Pharmacology. 80: 153-63. PMID 11934258 DOI: 10.1139/Y02-014 |
0.467 |
|
| 2002 |
Calo' G, Rizzi A, Bigoni R, Guerrini R, Salvadori S, Regoli D. Pharmacological profile of nociceptin/orphanin FQ receptors. Clinical and Experimental Pharmacology & Physiology. 29: 223-8. PMID 11906488 DOI: 10.1046/J.1440-1681.2002.03633.X |
0.545 |
|
| 2002 |
Redrobe JP, Calo' G, Regoli D, Quirion R. Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. Naunyn-Schmiedeberg's Archives of Pharmacology. 365: 164-7. PMID 11819035 DOI: 10.1007/S00210-001-0511-0 |
0.458 |
|
| 2002 |
Camarda V, Rizzi A, Calò G, Gendron G, Perron SI, Kostenis E, Zamboni P, Mascoli F, Regoli D. Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents. Naunyn-Schmiedeberg's Archives of Pharmacology. 365: 141-9. PMID 11819032 DOI: 10.1007/S00210-001-0503-0 |
0.378 |
|
| 2002 |
Emanueli C, Bonaria Salis M, Stacca T, Pintus G, Kirchmair R, Isner JM, Pinna A, Gaspa L, Regoli D, Cayla C, Pesquero JB, Bader M, Madeddu P. Targeting kinin B(1) receptor for therapeutic neovascularization. Circulation. 105: 360-6. PMID 11804993 DOI: 10.1161/Hc0302.102142 |
0.369 |
|
| 2002 |
Rizzi D, Rizzi A, Bigoni R, Camarda V, Marzola G, Guerrini R, De Risi C, Regoli D, Calo' G. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies. The Journal of Pharmacology and Experimental Therapeutics. 300: 57-63. PMID 11752097 DOI: 10.1124/Jpet.300.1.57 |
0.529 |
|
| 2001 |
Giannuario AD, Rizzi A, Pieretti S, Guerrini R, Bertorelli R, Salvadori S, Regoli D, Calo G. Studies on the antinociceptive effect of [Nphe1]nociceptin(1-13)NH2 in mice. Neuroscience Letters. 316: 25-28. PMID 11720770 DOI: 10.1016/S0304-3940(01)02352-7 |
0.461 |
|
| 2001 |
Guerrini R, Caló G, Bigoni R, Rizzi D, Rizzi A, Zucchini M, Varani K, Hashiba E, Lambert DG, Toth G, Borea PA, Salvadori S, Regoli D. Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor. Journal of Medicinal Chemistry. 44: 3956-64. PMID 11689082 DOI: 10.1021/Jm010221V |
0.413 |
|
| 2001 |
Rizzi A, Marzola G, Bigoni R, Guerrini R, Salvadori S, Mogil JS, Regoli D, Calò G. Endogenous nociceptin signaling and stress-induced analgesia. Neuroreport. 12: 3009-13. PMID 11568627 DOI: 10.1097/00001756-200110080-00006 |
0.375 |
|
| 2001 |
Rizzi D, Bigoni R, Rizzi A, Jenck F, Wichmann J, Guerrini R, Regoli D, Calo G. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Naunyn-Schmiedebergs Archives of Pharmacology. 363: 551-555. PMID 11383716 DOI: 10.1007/S002100100399 |
0.498 |
|
| 2001 |
Guerrini R, Calo' G, Bigoni R, Rizzi D, Regoli D, Salvadori S. Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist. The Journal of Peptide Research : Official Journal of the American Peptide Society. 57: 215-22. PMID 11298922 DOI: 10.1111/J.1399-3011.2001.00820.X |
0.504 |
|
| 2001 |
Regoli D, Rizzi A, Perron SI, Gobeil F. Classification of kinin receptors. Biological Chemistry. 382: 31-5. PMID 11258668 DOI: 10.1515/Bc.2001.005 |
0.59 |
|
| 2001 |
Farmer PJ, Bernier SG, Lepage A, Guillemette G, Regoli D, Sirois P. Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins. American Journal of Physiology. Lung Cellular and Molecular Physiology. 280: L732-8. PMID 11238014 DOI: 10.1152/Ajplung.2001.280.4.L732 |
0.376 |
|
| 2001 |
Rizzi A, Bigoni R, Marzola G, Guerrini R, Salvadori S, Regoli D, Calo' G. Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 363: 161-5. PMID 11218068 DOI: 10.1007/S002100000358 |
0.418 |
|
| 2001 |
Quartara L, Ricci R, Meini S, Patacchini R, Giolitti A, Amadesi S, Rizzi C, Rizzi A, Varani K, Borea PA, Maggi CA, Regoli D. Ala scan analogues of HOE 140. Synthesis and biological activities. European Journal of Medicinal Chemistry. 35: 1001-10. PMID 11137228 DOI: 10.1016/S0223-5234(00)01182-X |
0.437 |
|
| 2001 |
Rizzi A, Bigoni R, Marzola G, Guerrini R, Salvadori S, Regoli D, Calo G. The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia. Neuroreport. 11: 2369-72. PMID 10943687 DOI: 10.1097/00001756-200008030-00007 |
0.403 |
|
| 2000 |
Bigoni R, Rizzi A, Rizzi D, Becker JA, Kieffer BL, Simonin F, Regoli D, Calo G. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors. Life Sciences. 68: 233-9. PMID 11191640 DOI: 10.1016/S0024-3205(00)00931-0 |
0.527 |
|
| 2000 |
Redrobe JP, Calo G, Guerrini R, Regoli D, Quirion R. [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats. British Journal of Pharmacology. 131: 1379-84. PMID 11090110 DOI: 10.1038/Sj.Bjp.0703724 |
0.38 |
|
| 2000 |
Mazenot C, Gobeil F, Ribuot C, Regoli D, Godin-Ribuot D. Delayed myocardial protection induced by endotoxin does not involve kinin B(1)-receptors. British Journal of Pharmacology. 131: 740-4. PMID 11030723 DOI: 10.1038/Sj.Bjp.0703619 |
0.408 |
|
| 2000 |
Calo G, Bigoni R, Rizzi A, Guerrini R, Salvadori S, Regoli D. Nociceptin/orphanin FQ receptor ligands Peptides. 21: 935-947. PMID 10998527 DOI: 10.1016/S0196-9781(00)00230-8 |
0.477 |
|
| 2000 |
Guerrini R, Calo G, Rizzi A, Bigoni R, Rizzi D, Regoli D, Salvadori S. Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A. Peptides. 21: 923-933. PMID 10998526 DOI: 10.1016/S0196-9781(00)00229-1 |
0.503 |
|
| 2000 |
Bertorelli R, Calò G, Ongini E, Regoli D. Nociceptin/orpanin FQ and its receptor: a potential target for drug discovery. Trends in Pharmacological Sciences. 21: 233-4. PMID 10979861 DOI: 10.1016/S0165-6147(00)01492-9 |
0.372 |
|
| 2000 |
Guerrini R, Caló G, Bigoni R, Rizzi A, Varani K, Toth G, Gessi S, Hashiba E, Hashimoto Y, Lambert DG, Borea PA, Tomatis R, Salvadori S, Regoli D. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. Journal of Medicinal Chemistry. 43: 2805-13. PMID 10956188 DOI: 10.1021/Jm990075H |
0.517 |
|
| 2000 |
Pheng LH, Regoli D. Receptors for NPY in peripheral tissues bioassays. Life Sciences. 67: 847-62. PMID 10946845 DOI: 10.1016/S0024-3205(00)00679-2 |
0.753 |
|
| 2000 |
Polidori C, Calo G, Ciccocioppo R, Guerrini R, Regoli D, Massi M. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology. 148: 430-7. PMID 10928317 DOI: 10.1007/S002130050073 |
0.455 |
|
| 2000 |
Regoli D. Toward a new anti-inflammatory and analgesic agent. Proceedings of the National Academy of Sciences of the United States of America. 97: 7676-7. PMID 10869442 DOI: 10.1073/Pnas.150233397 |
0.519 |
|
| 2000 |
Pheng LH, Calo G, Guerrini R, Regoli D. [Nphe(1)]nociceptin-(1-13)NH(2) selectively antagonizes nociceptin effects in the rabbit isolated ileum. European Journal of Pharmacology. 397: 383-8. PMID 10844138 DOI: 10.1016/S0014-2999(00)00300-9 |
0.79 |
|
| 2000 |
Hallé S, Gobeil F, Ouellette J, Lambert C, Regoli D. In vitro and in vivo effects of kinin B 1 and B 2 receptor agonists and antagonists in inbred control and cardiomyopathic hamsters British Journal of Pharmacology. 129: 1641-1648. PMID 10780969 DOI: 10.1038/Sj.Bjp.0703269 |
0.518 |
|
| 2000 |
Calo G, Guerrini R, Rizzi A, Salvadori S, Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target British Journal of Pharmacology. 129: 1261-1283. PMID 10742280 DOI: 10.1038/Sj.Bjp.0703219 |
0.538 |
|
| 2000 |
Calo' G, Guerrini R, Bigoni R, Rizzi A, Marzola G, Okawa H, Bianchi C, Lambert DG, Salvadori S, Regoli D. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. British Journal of Pharmacology. 129: 1183-93. PMID 10725267 DOI: 10.1038/Sj.Bjp.0703169 |
0.566 |
|
| 2000 |
Dumont Y, Cadieux A, Doods H, Pheng LH, Abounader R, Hamel E, Jacques D, Regoli D, Quirion R. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. British Journal of Pharmacology. 129: 1075-88. PMID 10725255 DOI: 10.1038/Sj.Bjp.0703162 |
0.785 |
|
| 2000 |
Polidori C, Ciccocioppo R, Regoli D, Massi M. Neuropeptide Y receptor(s) mediating feeding in the rat: characterization with antagonists. Peptides. 21: 29-35. PMID 10704716 DOI: 10.1016/S0196-9781(99)00170-9 |
0.443 |
|
| 2000 |
Salvadori S, Guerrini R, Calo G, Regoli D. Structure-activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist. Farmaco (Societa Chimica Italiana : 1989). 54: 810-25. PMID 10668183 DOI: 10.1016/S0014-827X(99)00108-1 |
0.505 |
|
| 2000 |
Rizzi C, Rizzi A, Calò G, Jorizzo G, Agnello G, Mollica G, Inamura N, Regoli D. Characterization of FR 172357, a new non-peptide bradykinin B(2) receptor antagonist, in human, pig and rabbit preparations. European Journal of Pharmacology. 386: 25-31. PMID 10611460 DOI: 10.1016/S0014-2999(99)00711-6 |
0.505 |
|
| 2000 |
Rizzi A, Bigoni R, Caló G, Guerrini R, Salvadori S, Regoli D. [Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon. European Journal of Pharmacology. 385: R3-5. PMID 10607891 DOI: 10.1016/S0014-2999(99)00730-X |
0.499 |
|
| 2000 |
Gobeil F, Montagne M, Inamura N, Regoli D. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657). Immunopharmacology. 43: 179-85. PMID 10596851 DOI: 10.1016/S0162-3109(99)00129-0 |
0.514 |
|
| 1999 |
Rizzi A, Rizzi C, Amadesi S, Calo' G, Varani K, Inamura N, Regoli D. Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 360: 361-7. PMID 10551272 DOI: 10.1007/S002109900087 |
0.565 |
|
| 1999 |
Varani K, Rizzi A, Calo G, Bigoni R, Toth G, Guerrini R, Gessi S, Salvadori S, Borea PA, Regoli D. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies. Naunyn-Schmiedebergs Archives of Pharmacology. 360: 270-277. PMID 10543428 DOI: 10.1007/S002109900074 |
0.488 |
|
| 1999 |
Perron MS, Gobeil F, Pelletier S, Regoli D, Sirois P. Involvement of bradykinin B1 and B2 receptors in pulmonary leukocyte accumulation induced by Sephadex beads in guinea pigs. European Journal of Pharmacology. 376: 83-9. PMID 10440093 DOI: 10.1016/S0014-2999(99)00348-9 |
0.376 |
|
| 1999 |
Bregola G, Varani K, Gessi S, Beani L, Bianchi C, Borea PA, Regoli D, Simonato M. Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy. Neuroscience. 92: 1043-1049. PMID 10426544 DOI: 10.1016/S0306-4522(99)00075-5 |
0.505 |
|
| 1999 |
Pheng LH, Perron A, Quirion R, Cadieux A, Fauchère JL, Dumont Y, Regoli D. Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon. European Journal of Pharmacology. 374: 85-91. PMID 10422644 DOI: 10.1016/S0014-2999(99)00296-4 |
0.787 |
|
| 1999 |
Emanueli C, Chao J, Regoli D, Chao L, Ni A, Madeddu P. The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats. British Journal of Pharmacology. 126: 1769-76. PMID 10372819 DOI: 10.1038/Sj.Bjp.0702527 |
0.458 |
|
| 1999 |
Rizzi A, Calò G, Trevisani M, Tognetto M, Fabbri L, Mapp C, Guerrini R, Salvadori S, Regoli D, Geppetti P. Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus. Life Sciences. 64: PL157-63. PMID 10210279 DOI: 10.1016/S0024-3205(99)00045-4 |
0.46 |
|
| 1999 |
Bigoni R, Giuliani S, Calo' G, Rizzi A, Guerrini R, Salvadori S, Regoli D, Maggi CA. Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn-Schmiedeberg's Archives of Pharmacology. 359: 160-7. PMID 10208302 DOI: 10.1007/Pl00005338 |
0.461 |
|
| 1999 |
Madeddu P, Salis MB, Milia AF, Emanueli C, Guerrini R, Regoli D, Calò G. Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension (Dallas, Tex. : 1979). 33: 914-9. PMID 10082508 DOI: 10.1161/01.Hyp.33.3.914 |
0.439 |
|
| 1999 |
Gobeil F, Charland S, Filteau C, Perron SI, Neugebauer W, Regoli D. Kinin B1 receptor antagonists containing alpha-methyl-L-phenylalanine: in vitro and in vivo antagonistic activities. Hypertension. 33: 823-9. PMID 10082494 DOI: 10.1161/01.Hyp.33.3.823 |
0.521 |
|
| 1999 |
Varani K, Calo G, Rizzi A, Merighi S, Toth G, Guerrini R, Salvadori S, Borea PA, Regoli D. Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships. British Journal of Pharmacology. 125: 1485-90. PMID 9884077 DOI: 10.1038/Sj.Bjp.0702226 |
0.452 |
|
| 1999 |
Calò G, Rizzi A, Marzola G, Guerrini R, Salvadori S, Beani L, Regoli D, Bianchi C. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. British Journal of Pharmacology. 125: 373-8. PMID 9786511 DOI: 10.1038/Sj.Bjp.0702087 |
0.436 |
|
| 1998 |
Pheng LH, Regoli D. Bioassays for NPY receptors: old and new. Regulatory Peptides. 75: 79-87. PMID 9802396 DOI: 10.1016/S0167-0115(98)00055-X |
0.793 |
|
| 1998 |
Calo' G, Guerrini R, Bigoni R, Rizzi A, Bianchi C, Regoli D, Salvadori S. Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. Journal of Medicinal Chemistry. 41: 3360-6. PMID 9719588 DOI: 10.1021/Jm970805Q |
0.563 |
|
| 1998 |
Regoli D, Nsa Allogho S, Rizzi A, Gobeil FJ. Bradykinin receptors and their antagonists. European Journal of Pharmacology. 348: 1-10. PMID 9650825 DOI: 10.1016/S0014-2999(98)00165-4 |
0.579 |
|
| 1998 |
Emanueli C, Grady EF, Madeddu P, Figini M, Bunnett NW, Parisi D, Regoli D, Geppetti P. Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P. Hypertension (Dallas, Tex. : 1979). 31: 1299-304. PMID 9622145 DOI: 10.1161/01.Hyp.31.6.1299 |
0.417 |
|
| 1998 |
Nsa Allogho S, Gobeil F, Perron SI, Hess JF, Regoli D. Effects of kinins on isolated stomachs of control and transgenic knockout B2 receptor mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 357: 191-6. PMID 9550288 DOI: 10.1007/Pl00005157 |
0.512 |
|
| 1998 |
Guerrini R, Calo G, Rizzi A, Bigoni R, Bianchi C, Salvadori S, Regoli D. A new selective antagonist of the nociceptin receptor. British Journal of Pharmacology. 123: 163-5. PMID 9489602 DOI: 10.1038/Sj.Bjp.0701640 |
0.465 |
|
| 1998 |
Gessi S, Rizzi A, Calò G, Agnello G, Jorizzo G, Mollica G, Borea PA, Regoli D. Human vascular kinin receptors of the B2 type characterized by radioligand binding. British Journal of Pharmacology. 122: 1450-4. PMID 9421294 DOI: 10.1038/Sj.Bjp.0701536 |
0.506 |
|
| 1997 |
Rizzi A, Calò G, Amadesi S, Regoli D. Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems. Naunyn-Schmiedebergs Archives of Pharmacology. 356: 662-670. PMID 9402047 DOI: 10.1007/Pl00005103 |
0.558 |
|
| 1997 |
Ciccocioppo R, Panocka I, Polidori C, De Caro G, Regoli D, Massi M. Stimulation of tachykinin NK-3 receptors in the nucleus basalis magnocellularis reduces alcohol intake in rats. Peptides. 18: 1349-55. PMID 9392836 DOI: 10.1016/S0196-9781(97)00189-7 |
0.403 |
|
| 1997 |
Cellier E, Barbot L, Regoli D, Couture R. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat British Journal of Pharmacology. 122: 643-654. PMID 9375960 DOI: 10.1038/Sj.Bjp.0701435 |
0.42 |
|
| 1997 |
Regoli D, Rizzi A, Calò G. Pharmacology of the kallikrein-kinin system. Pharmacological Research. 35: 513-5. PMID 9356200 DOI: 10.1006/Phrs.1997.0178 |
0.358 |
|
| 1997 |
Pheng LH, Quirion R, Iyengar S, Fournier A, Regoli D. The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor. European Journal of Pharmacology. 333: R3-5. PMID 9314048 DOI: 10.1016/S0014-2999(97)01161-8 |
0.788 |
|
| 1997 |
Berthiaume N, Hess F, Chen A, Regoli D, D'Orléans-Juste P. Pharmacology of kinins in the arterial and venous mesenteric bed of normal and B2 knockout transgenic mice. European Journal of Pharmacology. 333: 55-61. PMID 9311661 DOI: 10.1016/S0014-2999(97)01096-0 |
0.417 |
|
| 1997 |
Polidori C, Panocka I, Ciccocioppo R, Broccardo M, Improta G, Regoli D, Massi M. Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptors. Peptides. 18: 825-33. PMID 9285931 DOI: 10.1016/S0196-9781(97)00022-3 |
0.49 |
|
| 1997 |
D'Orléans-Juste P, Sirois MG, Edelman ER, Regoli D, Pheng LH, Bkaily G, Lindsey CJ. DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors. Molecular and Cellular Biochemistry. 172: 199-211. PMID 9278246 |
0.729 |
|
| 1997 |
Pheng LH, Nguyen-Le XK, Nsa Allogho S, Gobeil F, Regoli D. Kinin receptors in the diabetic mouse. Canadian Journal of Physiology and Pharmacology. 75: 609-11. PMID 9276137 |
0.68 |
|
| 1997 |
Gobeil F, Neugebauer W, Nguyen-Le XK, Nea Allogho S, Pheng LH, Blouin D, Whalley ET, Regoli D. Pharmacological profiles of the human and rabbit B1 receptors. Canadian Journal of Physiology and Pharmacology. 75: 591-5. PMID 9276134 |
0.801 |
|
| 1997 |
Nsa Allogho S, Gobeil F, Pheng LH, Nguyen-Le XK, Neugebauer W, Regoli D. Antagonists for kinin B1 and B2 receptors in the mouse. Canadian Journal of Physiology and Pharmacology. 75: 558-62. PMID 9276128 |
0.786 |
|
| 1997 |
Nsa Allogho S, Nguyen-Le XK, Gobeil F, Pheng LH, Regoli D. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study. Canadian Journal of Physiology and Pharmacology. 75: 552-7. PMID 9276127 |
0.78 |
|
| 1997 |
Nguyen-Le XK, Neugebauer W, Gobeil F, Pheng LH, Nsa Allogho S, Regoli D. Pharmacological heterogeneity of neurotensin receptors: an in vitro study. Canadian Journal of Physiology and Pharmacology. 75: 547-51. PMID 9276126 |
0.788 |
|
| 1997 |
Regoli D, Rizzi A, Calo G, Nsa Allogho S, Gobeil F. B1 and B2 kinin receptors in various species. Immunopharmacology. 36: 143-7. PMID 9228538 DOI: 10.1016/S0162-3109(97)00013-1 |
0.521 |
|
| 1997 |
Figini M, Emanueli C, Bertrand C, Sicuteri R, Regoli D, Geppetti P. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea. British Journal of Pharmacology. 121: 773-81. PMID 9208147 DOI: 10.1038/Sj.Bjp.0701188 |
0.479 |
|
| 1997 |
Pheng LH, Fournier A, Dumont Y, Quirion R, Regoli D. The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y. European Journal of Pharmacology. 327: 163-7. PMID 9200555 DOI: 10.1016/S0014-2999(97)89656-2 |
0.787 |
|
| 1997 |
Guerrini R, Calo G, Rizzi A, Bianchi C, Lazarus LH, Salvadori S, Temussi PA, Regoli D. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. Journal of Medicinal Chemistry. 40: 1789-93. PMID 9191955 DOI: 10.1021/Jm970011B |
0.535 |
|
| 1997 |
Regoli D, Nguyen K, Caló G. Neurokinin receptors. Comparison of data from classical pharmacology, binding, and molecular biology. Annals of the New York Academy of Sciences. 812: 144-6. PMID 9186727 DOI: 10.1111/j.1749-6632.1997.tb48155.x |
0.315 |
|
| 1997 |
Salvadori S, Picone D, Tancredi T, Guerrini R, Spadaccini R, Lazarus LH, Regoli D, Temussi PA. Solution conformation of nociceptin Biochemical and Biophysical Research Communications. 233: 640-643. PMID 9168905 DOI: 10.1006/Bbrc.1997.6285 |
0.376 |
|
| 1997 |
Rizzi A, Gobeil F, Calò G, Inamura N, Regoli D. FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study. Hypertension (Dallas, Tex. : 1979). 29: 951-6. PMID 9095082 DOI: 10.1161/01.Hyp.29.4.951 |
0.568 |
|
| 1997 |
Calò G, Rizzi A, Traina L, Regoli D. Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery. Life Sciences. 60: PL63-8. PMID 9010490 DOI: 10.1016/S0024-3205(96)00635-2 |
0.487 |
|
| 1997 |
Bogoni G, Rizzi A, Calo G, Campobasso C, D'Orleans-Juste P, Regoli D. Characterization of endothelin receptors in the human umbilical artery and vein. British Journal of Pharmacology. 119: 1600-4. PMID 8982507 DOI: 10.1111/J.1476-5381.1996.Tb16078.X |
0.383 |
|
| 1997 |
Bonnet J, Kucharczyk N, Robineau P, Lonchampt M, Dacquet C, Regoli D, Fauchère JL, Canet E. A water-soluble, stable dipeptide NK1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523. European Journal of Pharmacology. 310: 37-46. PMID 8880065 DOI: 10.1016/0014-2999(96)00362-7 |
0.496 |
|
| 1997 |
Praddaude F, Tack I, Emond C, Bascands JL, Girolami JP, Tran-Van T, Regoli D, Ader JL. In vivo and in vitro homologous desensitization of rat glomerular bradykinin B2 receptors. European Journal of Pharmacology. 294: 173-82. PMID 8788429 DOI: 10.1016/0014-2999(95)00532-3 |
0.521 |
|
| 1997 |
Rizzi A, Gobeil F, Bogoni G, Calò G, Campobasso C, Inamura N, Regoli D. Antagonistic effects of FR 173657 on human, pig, rabbit, and guinea pig kinin receptors: an in vitro study Canadian Journal of Physiology and Pharmacology. 75: 601-608. DOI: 10.1139/Y97-051 |
0.308 |
|
| 1997 |
Fauchère J, Kucharczyk N, Jacoby E, Lonchampt M, Robineau P, Dacquet C, Regoli D, Canet E. The dipeptide neurokinin-1 receptor antagonist S19752 is a potent and long-acting inhibitor of bronchoconstriction when administered by aerosol to the guinea pig in vivo Bioorganic & Medicinal Chemistry Letters. 7: 203-208. DOI: 10.1016/S0960-894X(96)00604-X |
0.483 |
|
| 1997 |
Rémond G, Portevin B, Bonnet J, Canet E, Regoli D, De Nanteuil G. Pharmacological profile of a novel series of NK1 antagonists. In vitro and in vivo potency of benzimidazolone derivatives European Journal of Medicinal Chemistry. 32: 843-868. DOI: 10.1016/S0223-5234(97)82771-7 |
0.388 |
|
| 1997 |
D’Orléans-Juste P, Regoli D, Pheng LH, Bkaily G, Sirois MG, Edelman ER, Lindsey CJ. DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors Molecular and Cellular Biochemistry. 172: 199-211. DOI: 10.1007/978-1-4615-6353-2_20 |
0.36 |
|
| 1996 |
Nguyen-Le XK, Nguyen QT, Gobeil F, Jukic D, Chrétien L, Regoli D. Neurokinin receptors in the guinea pig ileum. Pharmacology. 52: 35-45. PMID 8966201 DOI: 10.1159/000139359 |
0.57 |
|
| 1996 |
Naline E, Molimard M, Regoli D, Emonds-Alt X, Bellamy JF, Advenier C. Evidence for functional tachykinin NK1 receptors on human isolated small bronchi. The American Journal of Physiology. 271: L763-7. PMID 8944719 DOI: 10.1152/Ajplung.1996.271.5.L763 |
0.494 |
|
| 1996 |
Gobeil F, Neugebauer W, Filteau C, Jukic D, Allogho SN, Pheng LH, Nguyen-Le XK, Blouin D, Regoli D. Structure-activity studies of B1 receptor-related peptides. Antagonists. Hypertension. 28: 833-9. PMID 8901831 DOI: 10.1161/01.Hyp.28.5.833 |
0.801 |
|
| 1996 |
Calò G, Rizzi A, Bogoni G, Neugebauer V, Salvadori S, Guerrini R, Bianchi C, Regoli D. The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. European Journal of Pharmacology. 311: R3-5. PMID 8884244 DOI: 10.1016/0014-2999(96)00563-8 |
0.311 |
|
| 1996 |
Regoli D, Calo G, Rizzi A, Bogoni G, Gobeil F, Campobasso C, Mollica G, Beani L. Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) Regulatory Peptides. 65: 83-89. PMID 8876040 DOI: 10.1016/0167-0115(96)00076-6 |
0.501 |
|
| 1996 |
Gobeil F, Filteau C, Pheng LH, Nguyen-Le XK, Regoli D. In vivo characterization of B2 receptors mediating hypotension in anesthetized rabbits and guinea pigs. Immunopharmacology. 33: 284-6. PMID 8856163 |
0.782 |
|
| 1996 |
Regoli D, Pheng LH, Allogho SN, Nguyen-Le XK, Gobeil F. Receptors for kinins: from classical pharmacology to molecular biology. Immunopharmacology. 33: 116-22. PMID 8856128 |
0.759 |
|
| 1996 |
Regoli D, Pheng LH, Allogho SN, Nguyen-Le XK, Gobeil F. Receptors for kinins: from classical pharmacology to molecular biology. Immunopharmacology. 33: 24-31. PMID 8856110 |
0.759 |
|
| 1996 |
Regoli D, Gobeil F. Pharmacology of kinin receptors: recent developments. Canadian Journal of Physiology and Pharmacology. 73: 791-6. PMID 8846411 DOI: 10.1139/Y95-107 |
0.547 |
|
| 1996 |
Nguyen-Le XK, Nguyen QT, Gobeil F, Pheng LH, Emonds-Alt X, Brelière JC, Regoli D. Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor. Pharmacology. 52: 283-91. PMID 8807672 DOI: 10.1159/000139393 |
0.798 |
|
| 1996 |
Gobeil F, Pheng LH, Badini I, Nguyen-Le XK, Pizard A, Rizzi A, Blouin D, Regoli D. Receptors for kinins in the human isolated umbilical vein. British Journal of Pharmacology. 118: 289-94. PMID 8735629 DOI: 10.1111/J.1476-5381.1996.Tb15401.X |
0.793 |
|
| 1996 |
Gobeil F, Filteau C, Pheng LH, Jukic D, Nguyen-Le XK, Regoli D. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig. Canadian Journal of Physiology and Pharmacology. 74: 137-44. PMID 8723025 |
0.782 |
|
| 1996 |
Caló G, Gratton JP, Télémaque S, D'Orléans-Juste P, Regoli D. Pharmacology of endothelins: vascular preparations for studying ETA and ETB receptors. Molecular and Cellular Biochemistry. 154: 31-7. PMID 8717414 DOI: 10.1007/Bf00248458 |
0.451 |
|
| 1996 |
Lopes P, Kar S, Chrétien L, Regoli D, Quirion R, Couture R. Quantitative autoradiographic localization of [125I-Tyr8]bradykinin receptor binding sites in the rat spinal cord: effects of neonatal capsaicin, noradrenergic deafferentation, dorsal rhizotomy and peripheral axotomy. Neuroscience. 68: 867-81. PMID 8577380 DOI: 10.1016/0306-4522(95)00161-B |
0.389 |
|
| 1996 |
Hipskind PA, Howbert JJ, Bruns RF, Cho SS, Crowell TA, Foreman MM, Gehlert DR, Iyengar S, Johnson KW, Krushinski JH, Li DL, Lobb KL, Mason NR, Muehl BS, Nixon JA, ... ... Regoli D, et al. 3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists. Journal of Medicinal Chemistry. 39: 736-48. PMID 8576917 DOI: 10.1021/Jm950616C |
0.433 |
|
| 1996 |
Nicolau M, Feltrin MR, Regoli D. Induction of bradykinin B1 hypotensive receptors in rats by lipopolysaccharide Canadian Journal of Physiology and Pharmacology. 74: 337-340. DOI: 10.1139/Y96-013 |
0.386 |
|
| 1995 |
Allogho SN, Gobeil F, Pheng LH, Nguyen-Le XK, Neugebauer W, Regoli D. Kinin B1 and B2 receptors in the mouse. Canadian Journal of Physiology and Pharmacology. 73: 1759-64. PMID 8834490 |
0.768 |
|
| 1995 |
Robineau P, Lonchampt M, Kucharczyk N, Krause JE, Regoli D, Fauchere JL, Prost JF, Canet E. In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist. European Journal of Pharmacology. 294: 677-84. PMID 8750733 DOI: 10.1016/0014-2999(95)00604-4 |
0.409 |
|
| 1995 |
Berthiaume N, Claing A, Regoli D, Warner TD, D'Orléans-Juste P. Characterization of receptors for kinins and neurokinins in the arterial and venous mesenteric vasculatures of the guinea-pig. British Journal of Pharmacology. 115: 1319-25. PMID 7582563 DOI: 10.1111/J.1476-5381.1995.Tb15043.X |
0.436 |
|
| 1995 |
Daniel EE, Parrish MB, Watson EG, Fox-Threlkeld JE, Regoli D, Rainsford KD. The tachykinin receptors inducing contractile responses of canine ileum circular muscle. The American Journal of Physiology. 268: G161-70. PMID 7530911 DOI: 10.1152/AJPGI.1995.268.1.G161 |
0.402 |
|
| 1995 |
Nguyen QT, Jukic D, Chrétien L, Gobeil F, Boussougou M, Regoli D. Two NK-3 receptor subtypes: demonstration by biological and binding assays. Neuropeptides. 27: 157-61. PMID 7529376 DOI: 10.1016/0143-4179(94)90065-5 |
0.503 |
|
| 1994 |
Regoli D, Jukic D, Gobeil F, Rhaleb NE. Receptors for bradykinin and related kinins: a critical analysis. Canadian Journal of Physiology and Pharmacology. 71: 556-67. PMID 8306193 DOI: 10.1139/Y93-079 |
0.563 |
|
| 1994 |
Regoli D, Nguyen QT, Jukic D. Neurokinin receptor subtypes characterized by biological assays Life Sciences. 54: 2035-2047. PMID 8208061 DOI: 10.1016/0024-3205(94)00712-8 |
0.565 |
|
| 1994 |
Willis S, Allescher HD, Schusdziarra V, Regoli D, Drapeau G, Classen M. Differential effects of selective neurokinin agonists on phasic and tonic activity in rat ileal longitudinal muscle. Neuropeptides. 25: 315-23. PMID 8115033 DOI: 10.1016/0143-4179(93)90049-G |
0.455 |
|
| 1994 |
Regoli D, Gobeil F, Nguyen QT, Jukic D, Seoane PR, Salvino JM, Sawutz DG. Bradykinin receptor types and B2 subtypes. Life Sciences. 55: 735-49. PMID 8072371 DOI: 10.1016/0024-3205(94)00557-5 |
0.583 |
|
| 1994 |
Coge F, Regoli D. NK1 and NK2 receptors are similar in man and rabbit. Neuropeptides. 26: 385-90. PMID 7523978 DOI: 10.1016/0143-4179(94)90023-X |
0.495 |
|
| 1994 |
Picard P, Regoli D, Couture R. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. British Journal of Pharmacology. 112: 240-9. PMID 7518304 DOI: 10.1111/J.1476-5381.1994.Tb13058.X |
0.519 |
|
| 1994 |
Chrétien L, Guillemette G, Regoli D. Non-peptide angiotensin receptor antagonists bind to tachykinin NK3 receptors of rat and guinea pig brain. European Journal of Pharmacology. 256: 73-8. PMID 7517891 DOI: 10.1016/0014-2999(94)90618-1 |
0.528 |
|
| 1994 |
Gitter BD, Regoli D, Howbert JJ, Glasebrook AL, Waters DC. Interleukin-6 secretion from human astrocytoma cells induced by substance P. Journal of Neuroimmunology. 51: 101-8. PMID 7512575 DOI: 10.1016/0165-5728(94)90134-1 |
0.378 |
|
| 1994 |
Lopes P, Regoli D, Couture R. Cardiovascular effects of intrathecally administered bradykinin in the rat: characterization of receptors with antagonists. British Journal of Pharmacology. 110: 1369-74. PMID 7508324 DOI: 10.1111/J.1476-5381.1993.Tb13971.X |
0.443 |
|
| 1994 |
Calo G, Telemaque S, Gratton JP, D'Orleans-Juste P, Regoli D. Pharmacology of endothelins: preparations and use of preventive or curative protocols for evaluating antagonists of the ETA and ETB receptors ☆ Neuropeptides. 26: 36. DOI: 10.1016/0143-4179(94)90224-0 |
0.474 |
|
| 1994 |
Regoli D, Nguyen Q, Gobeil F, Jukic D. Pharmacology of neurokinins: New preparations for characterization of receptor subtypes Neuropeptides. 26: 30. DOI: 10.1016/0143-4179(94)90207-0 |
0.488 |
|
| 1993 |
Regoli D, D'Orléans-Juste P, Rouissi N, Rhaleb NE. Vasoactive peptides and characterization of their receptors. Regulatory Peptides. 45: 323-340. PMID 8394593 DOI: 10.1016/0167-0115(93)90359-G |
0.478 |
|
| 1993 |
Kucharczyk N, Thurieau C, Paladino J, Morris AD, Bonnet J, Canet E, Krause JE, Regoli D, Couture R, Fauchère JL. Tetrapeptide tachykinin antagonists: synthesis and modulation of the physicochemical and pharmacological properties of a new series of partially cyclic analogs. Journal of Medicinal Chemistry. 36: 1654-61. PMID 8388471 DOI: 10.1021/Jm00063A015 |
0.357 |
|
| 1993 |
Chahine R, Adam A, Yamaguchi N, Gaspo R, Regoli D, Nadeau R. Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor. British Journal of Pharmacology. 108: 318-22. PMID 8383560 DOI: 10.1111/j.1476-5381.1993.tb12802.x |
0.347 |
|
| 1993 |
Paladino J, Thurieau C, Morris AD, Kucharczyk N, Rouissi N, Regoli D, Fauchère JL. Synthesis and in vitro activities of new tryptophan-modified and thiomethylene-containing pseudopeptide antagonists of the neurokinins. International Journal of Peptide and Protein Research. 42: 284-93. PMID 8225784 DOI: 10.1111/J.1399-3011.1993.Tb00144.X |
0.342 |
|
| 1993 |
Ribuot C, Godin D, Couture R, Regoli D, Nadeau R. In vivo B2-receptor-mediated negative chronotropic effect of bradykinin in canine sinus node. The American Journal of Physiology. 265: H876-9. PMID 8105700 DOI: 10.1152/Ajpheart.1993.265.3.H876 |
0.467 |
|
| 1993 |
Bueb JL, Mousli M, Landry Y, Regoli D. Structure-activity studies of bradykinin analogues on rat mast cell histamine release. Peptides. 14: 685-9. PMID 7694261 DOI: 10.1016/0196-9781(93)90098-2 |
0.33 |
|
| 1993 |
Couture R, Boucher S, Picard P, Regoli D. Receptor characterization of the spinal action of neurokinins on nociception: a three receptor hypothesis. Regulatory Peptides. 46: 426-9. PMID 7692557 DOI: 10.1016/0167-0115(93)90109-L |
0.477 |
|
| 1993 |
Culman J, Tschöpe C, Picard P, Prat A, Regoli D, Couture R, Unger T. In vivo characterization of tachykinin receptors responsible for the central cardiovascular effects of substance P and neurokinin A. Regulatory Peptides. 46: 364-6. PMID 7692538 DOI: 10.1016/0167-0115(93)90087-O |
0.464 |
|
| 1993 |
Regoli D, Nguyen QT, Jukic D, Rouissi N. Functional characterization of neurokinin receptors with agonists and antagonists Regulatory Peptides. 46: 287-289. PMID 7692518 DOI: 10.1016/0167-0115(93)90062-D |
0.522 |
|
| 1993 |
Nicolau M, Sirois MG, Bui M, Plante GE, Sirois P, Regoli D. Plasma extravasation induced by neurokinins in conscious rats: receptor characterization with agonists and antagonists. Canadian Journal of Physiology and Pharmacology. 71: 217-21. PMID 7691388 DOI: 10.1139/Y93-034 |
0.514 |
|
| 1993 |
Picard P, Boucher S, Regoli D, Gitter BD, Howbert JJ, Couture R. Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat. European Journal of Pharmacology. 232: 255-61. PMID 7682180 DOI: 10.1016/0014-2999(93)90782-D |
0.498 |
|
| 1993 |
Rouissi N, Claing A, Nicolau M, Jukic D, D'Orléans-Juste P, Regoli D. Substance P (NK-1 receptor) antagonists: in vivo and in vitro activities in rats and guinea pigs. Life Sciences. 52: 1141-7. PMID 7680744 DOI: 10.1016/0024-3205(93)90436-7 |
0.533 |
|
| 1993 |
Rouissi N, Jukic D, D'Orléans-Juste P, Regoli D. A potent and long-acting NK-1 selective agonist. Life Sciences. 52: PL103-6. PMID 7680743 DOI: 10.1016/0024-3205(93)90438-9 |
0.451 |
|
| 1993 |
Tschöpe C, Picard P, Culman J, Prat A, Itoi K, Regoli D, Unger T, Couture R. Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat. British Journal of Pharmacology. 107: 750-5. PMID 1335337 DOI: 10.1111/J.1476-5381.1992.Tb14518.X |
0.529 |
|
| 1993 |
Rovero P, Astolfi M, Manzini S, Jukic D, Rouissi N, Maggi CA, Regoli D. Structure-activity relationship study of R396, an NK2 tachykinin antagonist selective for the NK2B receptor subtype. Neuropeptides. 23: 143-5. PMID 1335133 DOI: 10.1016/0143-4179(92)90114-C |
0.452 |
|
| 1993 |
Tousignant C, Regoli D, Rhaleb NE, Jukic D, Guillemette G. 125I-Tyr,D-Arg[Hyp3,D-Phe7,Leu8]BK, a radiolabelled B2 antagonist specifically interacts with two distinct binding sites on epithelial membranes of guinea pig ileum. Agents and Actions. Supplements. 526-39. PMID 1334630 DOI: 10.1007/978-3-0348-7321-5_64 |
0.316 |
|
| 1993 |
Regoli D, Jukic D, Tousignant C, Rhaleb NE. Kinin receptor classification. Agents and Actions. Supplements. 475-86. PMID 1334627 DOI: 10.1007/978-3-0348-7321-5_60 |
0.322 |
|
| 1993 |
Tousignant C, Chrétien L, Guillemette G, Regoli D. Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonist. Brain Research. 596: 243-50. PMID 1281744 DOI: 10.1016/0006-8993(92)91554-R |
0.452 |
|
| 1993 |
Regoli D, Couture R. Neurokinin receptor antagonists Neuropeptides. 24: 232-233. DOI: 10.1016/0143-4179(93)90242-3 |
0.446 |
|
| 1992 |
Cirino G, Cicala C, Sorrentino L, Regoli D. Effect of bradykinin antagonists, NG-monomethyl-L-arginine and L-NG-nitro arginine on phospholipase A2 induced oedema in rat paw. General Pharmacology. 22: 801-4. PMID 1761183 DOI: 10.1016/0306-3623(91)90209-O |
0.387 |
|
| 1992 |
Rollandy I, Guillemain I, Imhoff V, Drapeau G, Regoli D, Rossignol B. Involvement of NK1 receptors and importance of the N-terminal sequence of substance P in the stimulation of protein secretion in rat parotid glands. European Journal of Pharmacology. 209: 95-100. PMID 1726089 DOI: 10.1016/0014-2999(91)90016-J |
0.374 |
|
| 1992 |
Tousignant C, Guillemette G, Regoli D. Binding sites for [3H][Sar9, Met(O2)11]substance P in rat brain and guinea pig ileum. Brain Research. 560: 1-11. PMID 1722129 DOI: 10.1016/0006-8993(91)91207-H |
0.394 |
|
| 1992 |
Nantel F, Rouissi N, Rhaleb NE, Jukic D, Regoli D. Pharmacological evaluation of the angiotensin, kinin, and neurokinin receptors on the rabbit vena cava. Journal of Cardiovascular Pharmacology. 18: 398-405. PMID 1720840 DOI: 10.1097/00005344-199109000-00013 |
0.47 |
|
| 1992 |
Rhaleb NE, Rouissi N, Jukic D, Regoli D, Henke S, Breipohl G, Knolle J. Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin). European Journal of Pharmacology. 210: 115-20. PMID 1601053 DOI: 10.1016/0014-2999(92)90661-M |
0.547 |
|
| 1992 |
Rhaleb NE, Gobeil F, Regoli D. Non-selectivity of new bradykinin antagonists for B1 receptors. Life Sciences. 51: PL125-9. PMID 1326066 DOI: 10.1016/0024-3205(92)90617-X |
0.545 |
|
| 1992 |
Tousignant C, Regoli D, Rhaleb NE, Jukic D, Guillemette G. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum. European Journal of Pharmacology. 225: 235-44. PMID 1325366 DOI: 10.1016/0922-4106(92)90025-Q |
0.374 |
|
| 1992 |
Advenier C, Rouissi N, Nguyen QT, Emonds-Alt X, Breliere JC, Neliat G, Naline E, Regoli D. Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochemical and Biophysical Research Communications. 184: 1418-24. PMID 1317173 DOI: 10.1016/S0006-291X(05)80041-5 |
0.497 |
|
| 1992 |
Lortie M, Regoli D, Rhaleb NE, Plante GE. The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. The American Journal of Physiology. 262: R72-6. PMID 1310238 DOI: 10.1152/Ajpregu.1992.262.1.R72 |
0.429 |
|
| 1992 |
Regoli D. Receptors for substance P and related neurokinins functional characterization Regulatory Peptides. 37: S135. DOI: 10.1016/0167-0115(92)90990-C |
0.439 |
|
| 1992 |
Couture R, Boucher S, Picard P, Regoli D. Receptor characterization of the spinal action of neurokinins on nociception: A three receptor hypothesis Regulatory Peptides. 37: S48. DOI: 10.1016/0167-0115(92)90903-8 |
0.374 |
|
| 1992 |
Rovero P, Astolfi M, Jukic D, Rouissi N, Regoli D, Maggi CA. Structure-activity study of R 396, an NK-2 receptor antagonist selective for the NK-2B receptor subtype Neuropeptides. 22: 58-59. DOI: 10.1016/0143-4179(92)90485-F |
0.513 |
|
| 1992 |
Regoli D, Rouissi N, Chrétien L, Couture R, Picard P, Jukic D. Pharmacology of neurokinin receptor antagonists Neuropeptides. 22: 55-56. DOI: 10.1016/0143-4179(92)90478-F |
0.541 |
|
| 1991 |
Emond C, Bascands JL, Pecher C, Cabos-Boutot G, Pradelles P, Regoli D, Girolami JP. Characterization of a B2-bradykinin receptor in rat renal mesangial cells. European Journal of Pharmacology. 190: 381-92. PMID 2176985 DOI: 10.1016/0014-2999(90)94203-A |
0.435 |
|
| 1991 |
Drapeau G, Rouissi N, Nantel F, Rhaleb NE, Tousignant C, Regoli D. Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems. Regulatory Peptides. 31: 125-35. PMID 2176308 DOI: 10.1016/0167-0115(90)90115-D |
0.555 |
|
| 1991 |
Dion S, Rouissi N, Nantel F, Jukic D, Rhaleb NE, Tousignant C, Télémaque S, Drapeau G, Regoli D, Naline E. Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptor. Pharmacology. 41: 184-94. PMID 1964226 DOI: 10.1159/000138717 |
0.538 |
|
| 1991 |
Hölzemann G, Jonczyk A, Eiermann V, Pachler KG, Barnickel G, Regoli D. Conformation-based design of two cyclic physalaemin analogues. Biopolymers. 31: 691-7. PMID 1932567 DOI: 10.1002/Bip.360310614 |
0.374 |
|
| 1991 |
Rhaleb NE, Télémaque S, Rouissi N, Dion S, Jukic D, Drapeau G, Regoli D. Structure-activity studies of bradykinin and related peptides. B2-receptor antagonists. Hypertension (Dallas, Tex. : 1979). 17: 107-15. PMID 1846119 DOI: 10.1161/01.Hyp.17.1.107 |
0.578 |
|
| 1991 |
Geppetti P, Fusco BM, Alessandri M, Tramontana M, Maggi CA, Drapeau G, Fanciullacci M, Regoli D. Kallidin applied to the human nasal mucosa produces algesic response not blocked by capsaicin desensitization. Regulatory Peptides. 33: 321-9. PMID 1831914 DOI: 10.1016/0167-0115(91)90234-8 |
0.383 |
|
| 1991 |
D'Orléans-Juste P, Claing A, Télémaque S, Warner TD, Regoli D. Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed. European Journal of Pharmacology. 204: 329-34. PMID 1723050 DOI: 10.1016/0014-2999(91)90860-S |
0.445 |
|
| 1991 |
Rhaleb NE, Rouissi N, Drapeau G, Jukic D, Regoli D. Characterization of bradykinin receptors in peripheral organs. Canadian Journal of Physiology and Pharmacology. 69: 938-43. PMID 1720068 DOI: 10.1139/Y91-142 |
0.577 |
|
| 1991 |
Abelli L, Nappi F, Maggi CA, Rovero P, Astolfi M, Regoli D, Drapeau G, Giachetti A. NK-1 receptors and vascular permeability in rat airways. Annals of the New York Academy of Sciences. 632: 358-9. PMID 1719879 DOI: 10.1111/J.1749-6632.1991.Tb33123.X |
0.456 |
|
| 1991 |
Regoli D, Nantel F, Tousignant C, Jukic D, Rouissi N, Rhaleb NE, Télémaque S, Drapeau G, d'Orléans-Juste P. Neurokinin agonists and antagonists. Annals of the New York Academy of Sciences. 632: 170-83. PMID 1719863 DOI: 10.1111/j.1749-6632.1991.tb33105.x |
0.385 |
|
| 1991 |
Jukic D, Rouissi N, Laprise R, Boussougou M, Regoli D. Neurokinin receptors antagonists: Old and new Life Sciences. 49: 1463-1469. PMID 1719324 DOI: 10.1016/0024-3205(91)90045-D |
0.512 |
|
| 1991 |
Regoli D, Nantel F. Pharmacology of neurokinin receptors. Biopolymers. 31: 777-83. PMID 1718474 DOI: 10.1002/Bip.360310623 |
0.557 |
|
| 1991 |
Duplaa H, Chassaing G, Lavielle S, Beaujouan JC, Torrens Y, Saffroy M, Glowinski J, D'Orléans Juste P, Regoli D, Carruette A. Influence of the replacement of amino acid by its D-enantiomer in the sequence of substance P. 1. Binding and pharmacological data. Neuropeptides. 19: 251-7. PMID 1717876 DOI: 10.1016/0143-4179(91)90092-W |
0.353 |
|
| 1991 |
Humpel C, Saria A, Regoli D. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism. European Journal of Pharmacology. 195: 107-14. PMID 1712305 DOI: 10.1016/0014-2999(91)90387-6 |
0.402 |
|
| 1991 |
Rouissi N, Gitter BD, Waters DC, Howbert JJ, Nixon JA, Regoli D. Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P Biochemical and Biophysical Research Communications. 176: 894-901. PMID 1709018 DOI: 10.1016/S0006-291X(05)80270-0 |
0.48 |
|
| 1991 |
Tousignant C, Guillemette G, Drapeau G, Télémaque S, Dion S, Regoli D. 125I-BH[Sar9, Met(O2)11]-SP, a new selective ligand for the NK-1 receptor in the central nervous system. Brain Research. 524: 263-70. PMID 1705465 DOI: 10.1016/0006-8993(90)90700-L |
0.421 |
|
| 1991 |
Abelli L, Maggi CA, Rovero P, Del Bianco E, Regoli D, Drapeau G, Giachetti A. Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptors. Journal of Autonomic Pharmacology. 11: 267-75. PMID 1682326 DOI: 10.1111/J.1474-8673.1991.Tb00324.X |
0.461 |
|
| 1991 |
Rhaleb NE, Rouissi N, Nantel F, D'Orléans-Juste P, Regoli D. DuP 753 is a specific antagonist for the angiotensin receptor. Hypertension. 17: 480-484. PMID 1672862 DOI: 10.1161/01.Hyp.17.4.480 |
0.534 |
|
| 1991 |
Regoli D, Rhaleb NE, Tousignant C, Rouissi N, Nantel F, Jukic D, Drapeau G. New highly potent bradykinin B2 receptor antagonists. Inflammation Research. 34: 138-141. PMID 1665287 DOI: 10.1007/Bf01993260 |
0.56 |
|
| 1991 |
Regoli D, Rhaleb NE, Rouissi N, Tousignant C, Jukic D, Drapeau C. Activation of sensory nerves by kinins: pharmacologic tools for studying kinin receptors. Advances in Experimental Medicine and Biology. 298: 63-74. PMID 1659151 DOI: 10.1007/978-1-4899-0744-8_6 |
0.348 |
|
| 1991 |
Tousignant C, Guillemette G, Barabé J, Rhaleb NE, Regoli D. Characterization of kinin binding sites: identity of B2 receptors in the epithelium and the smooth muscle of the guinea pig ileum. Canadian Journal of Physiology and Pharmacology. 69: 818-25. PMID 1655182 DOI: 10.1139/Y91-123 |
0.398 |
|
| 1991 |
Rouissi N, Rhaleb NE, Nantel F, Dion S, Drapeau G, Regoli D. Characterization of bombesin receptors in peripheral contractile organs. British Journal of Pharmacology. 103: 1141-7. PMID 1652341 DOI: 10.1111/J.1476-5381.1991.Tb12314.X |
0.525 |
|
| 1991 |
Bascands JL, Emond C, Pecher C, Regoli D, Girolami JP. Bradykinin stimulates production of inositol (1,4,5) trisphosphate in cultured mesangial cells of the rat via a BK2-kinin receptor. British Journal of Pharmacology. 102: 962-6. PMID 1649661 DOI: 10.1111/J.1476-5381.1991.Tb12284.X |
0.43 |
|
| 1991 |
Jukic D, Mayer M, Schmitt P, Drapeau G, Regoli D, Michelot R. Synthesis and biological activities of neurokinin pseudopeptide analogues containing a reduced peptide bond European Journal of Medicinal Chemistry. 26: 921-928. DOI: 10.1016/0223-5234(91)90134-9 |
0.426 |
|
| 1990 |
Tousignant C, Guillemette G, Drapeau G, Regoli D. Comparison of binding assay and biological activity on a NK-1 system with new selective agonists. Neuropeptides. 14: 275-83. PMID 2482952 DOI: 10.1016/0143-4179(89)90057-7 |
0.409 |
|
| 1990 |
Regoli D, Rhaleb NE, Drapeau G, Dion S, Tousignant C, D'Orléans-Juste P, Devillier P. Basic pharmacology of kinins: pharmacologic receptors and other mechanisms. Advances in Experimental Medicine and Biology. 399-407. PMID 2481388 DOI: 10.1007/978-1-4615-9543-4_61 |
0.341 |
|
| 1990 |
Devillier P, Drapeau G, Renoux M, Regoli D. Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides. European Journal of Pharmacology. 168: 53-60. PMID 2479572 DOI: 10.1016/0014-2999(89)90632-8 |
0.437 |
|
| 1990 |
Maggi CA, Rovero P, Giuliani S, Evangelista S, Regoli D, Meli A. Biological activity of N-terminal fragments of calcitonin gene-related peptide. European Journal of Pharmacology. 179: 217-9. PMID 2364983 DOI: 10.1016/0014-2999(90)90422-3 |
0.354 |
|
| 1990 |
Regoli D, Dion S, Rhaleb NE, Drapeau G, D'Orléans-Juste P. Vasoactive peptides and their receptors. Blood Vessels. 27: 137-45. PMID 2173637 DOI: 10.1159/000158804 |
0.572 |
|
| 1990 |
Maggi CA, Patacchini R, Giuliani S, Rovero P, Dion S, Regoli D, Giachetti A, Meli A. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. British Journal of Pharmacology. 100: 589-92. PMID 2167737 DOI: 10.1111/J.1476-5381.1990.Tb15851.X |
0.522 |
|
| 1990 |
Nantel F, Rouissi N, Rhaleb NE, Dion S, Drapeau G, Regoli D. The rabbit jugular vein is a contractile NK-1 receptor system. European Journal of Pharmacology. 179: 457-62. PMID 2163859 DOI: 10.1016/0014-2999(90)90189-D |
0.477 |
|
| 1990 |
Regoli D, Rhaleb NE, Dion S, Drapeau G. New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization. Trends in Pharmacological Sciences. 11: 156-61. PMID 2159199 DOI: 10.1016/0165-6147(90)90067-I |
0.543 |
|
| 1990 |
Rhaleb NE, Drapeau G, Dion S, Jukic D, Rouissi N, Regoli D. Structure-activity studies on bradykinin and related peptides: agonists. British Journal of Pharmacology. 99: 445-8. PMID 2158842 DOI: 10.1111/J.1476-5381.1990.Tb12947.X |
0.539 |
|
| 1990 |
Regoli D, Rhaleb NE, Dion S, Tousignant C, Rouissi N, Jukic D, Drapeau G. Neurokinin A. A pharmacological study. Pharmacological Research. 22: 1-14. PMID 2158652 DOI: 10.1016/1043-6618(90)90738-Y |
0.553 |
|
| 1990 |
Rovero P, Pestellini V, Maggi CA, Patacchini R, Regoli D, Giachetti A. A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan. European Journal of Pharmacology. 175: 113-5. PMID 2157594 DOI: 10.1016/0014-2999(90)90161-X |
0.465 |
|
| 1990 |
Lew R, Geraghty DP, Drapeau G, Regoli D, Burcher E. Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor. European Journal of Pharmacology. 184: 97-108. PMID 1698645 DOI: 10.1016/0014-2999(90)90670-2 |
0.335 |
|
| 1990 |
Rouissi N, Nantel F, Drapeau G, Rhaleb NE, Dion S, Regoli D. Inhibitors of peptidases: how they influence the biological activities of substance P, neurokinins, bradykinin and angiotensin in guinea pig, hamster and rat urinary bladders. Pharmacology. 40: 196-204. PMID 1697075 DOI: 10.1159/000138659 |
0.372 |
|
| 1990 |
Rouissi N, Nantel F, Drapeau G, Rhaleb NE, Dion S, Regoli D. Inhibitors of peptidases: how they influence the biological activities of substance P, neurokinins, kinins and angiotensins in isolated vessels. Pharmacology. 40: 185-95. PMID 1697074 DOI: 10.1159/000138658 |
0.348 |
|
| 1990 |
Dion S, Rouissi N, Nantel F, Drapeau G, Regoli D, Naline E, Advenier C. Receptors for neurokinins in human bronchus and urinary bladder are of the NK-2 type. European Journal of Pharmacology. 178: 215-9. PMID 1691713 DOI: 10.1016/0014-2999(90)90477-N |
0.548 |
|
| 1990 |
Regoli D, Rhaleb N-, Drapeau G, Dion S. Kinin Receptor Subtypes Journal of Cardiovascular Pharmacology. 15: S30-S38. DOI: 10.1097/00005344-199000156-00007 |
0.57 |
|
| 1990 |
Santicioli P, Maggi C, Patacchini R, Giuliani S, Rovero P, Regoli D, Meli A, Giachetti A. Evidence for heterogeneity off NK-2 tachykinin receptors by using competitive antagonists European Journal of Pharmacology. 183: 2141-2142. DOI: 10.1016/0014-2999(90)93664-C |
0.51 |
|
| 1989 |
Barabé J, Regoli D. Kinin antagonists. Methods in Enzymology. 163: 282-92. PMID 3237080 DOI: 10.1016/0076-6879(88)63027-8 |
0.386 |
|
| 1989 |
Drapeau G, Rhaleb NE, Dion S, Jukic D, Regoli D. [Phe8 psi(CH2-NH)Arg9]bradykinin, a B2 receptor selective agonist which is not broken down by either kininase I or kininase II. European Journal of Pharmacology. 155: 193-5. PMID 2907489 DOI: 10.1016/0014-2999(88)90423-2 |
0.438 |
|
| 1989 |
Regoli D, Barabé J. Kinin receptors. Methods in Enzymology. 163: 210-30. PMID 2907091 DOI: 10.1016/0076-6879(88)63021-7 |
0.414 |
|
| 1989 |
Staszewska-Woolley J, Woolley G, Regoli D. Specific receptors for bradykinin-induced cardiac sympathetic chemoreflex in the dog. European Journal of Pharmacology. 156: 309-14. PMID 2905666 DOI: 10.1016/0014-2999(88)90275-0 |
0.532 |
|
| 1989 |
Regoli D, Drapeau G, Dion S, Couture R. New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Trends in Pharmacological Sciences. 9: 290-5. PMID 2854928 DOI: 10.1016/0165-6147(88)90013-2 |
0.537 |
|
| 1989 |
Regoli D, Dion S, Rhaleb NE, Drapeau G, Rouissi N, D'Orléans-Juste P. Receptors for neurokinins, tachykinins, and bombesin: a pharmacological study. Annals of the New York Academy of Sciences. 547: 158-73. PMID 2853591 DOI: 10.1111/J.1749-6632.1988.Tb23884.X |
0.536 |
|
| 1989 |
Regoli D. Multiple bradykinin B2 receptors. Trends in Pharmacological Sciences. 10: 138. PMID 2546302 DOI: 10.1016/0165-6147(89)90163-6 |
0.399 |
|
| 1989 |
Rovero P, Pestellini V, Rhaleb NE, Dion S, Rouissi N, Tousignant C, Télémaque S, Drapeau G, Regoli D. Structure-activity studies of neurokinin A. Neuropeptides. 13: 263-70. PMID 2546091 DOI: 10.1016/0143-4179(89)90080-2 |
0.417 |
|
| 1989 |
Rhaleb NE, Dion S, Barabé J, Rouissi N, Jukic D, Drapeau G, Regoli D. Receptors for kinins in isolated arterial vessels of dogs. European Journal of Pharmacology. 162: 419-27. PMID 2545457 DOI: 10.1016/0014-2999(89)90332-4 |
0.457 |
|
| 1989 |
Regoli D, Drapeau G, Dion S, D'Orléans-Juste P. Receptors for substance P and related neurokinins. Pharmacology. 38: 1-15. PMID 2542998 DOI: 10.1159/000138512 |
0.57 |
|
| 1989 |
Couture R, Laneuville O, Guimond C, Drapeau G, Regoli D. Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Naunyn-Schmiedeberg's Archives of Pharmacology. 340: 547-57. PMID 2482449 DOI: 10.1007/Bf00260610 |
0.336 |
|
| 1989 |
Jacques L, Couture R, Drapeau G, Regoli D. Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action. Naunyn-Schmiedeberg's Archives of Pharmacology. 340: 170-9. PMID 2478892 DOI: 10.1007/Bf00168965 |
0.354 |
|
| 1989 |
Daniel EE, Cipris S, Manaka Y, Bowker P, Regoli D. Classification of tachykinin receptors in muscularis mucosae of opossum oesophagus. British Journal of Pharmacology. 97: 1013-8. PMID 2477100 DOI: 10.1111/j.1476-5381.1989.tb12556.x |
0.411 |
|
| 1989 |
Naline E, Devillier P, Drapeau G, Toty L, Bakdach H, Regoli D, Advenier C. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. The American Review of Respiratory Disease. 140: 679-86. PMID 2476956 DOI: 10.1164/Ajrccm/140.3.679 |
0.499 |
|
| 1989 |
Allescher H-, Kostolanska F, Tougas G, Fox JET, Regoli D, Drapeau G, Daniel EE. The actions of neurokinins and substance P in canine pylorus, antrum and duodenum. Peptides. 10: 671-679. PMID 2476789 DOI: 10.1016/0196-9781(89)90158-7 |
0.493 |
|
| 1989 |
Abelli L, Somma V, Maggi CA, Regoli D, Astolfi M, Parlani M, Rovero P, Conte B, Meli A. Effects of tachykinins and selective tachykinin receptor agonists on vascular permeability in the rat lower urinary tract: evidence for the involvement of NK-1 receptors. Journal of Autonomic Pharmacology. 9: 253-63. PMID 2475507 DOI: 10.1111/J.1474-8673.1989.Tb00216.X |
0.544 |
|
| 1989 |
Maggi CA, Patacchini R, Renzi D, Santicioli P, Regoli D, Rovero P, Drapeau G, Surrenti C, Meli A. Effect of thiorphan on response of the guinea-pig gallbladder to tachykinins. European Journal of Pharmacology. 165: 51-61. PMID 2475353 DOI: 10.1016/0014-2999(89)90769-3 |
0.456 |
|
| 1989 |
Regoli D, Dion S, Rhaleb NE, Rouissi N, Tousignant C, Jukic D, D'Orleans-Juste P, Drapeau G. Selective agonists for receptors of substance P and related neurokinins. Biopolymers. 28: 81-90. PMID 2470440 DOI: 10.1002/Bip.360280111 |
0.563 |
|
| 1989 |
Marceau F, Tremblay B, Couture R, Regoli D. Prostacyclin release induced by neurokinins in cultured human endothelial cells Canadian Journal of Physiology and Pharmacology. 67: 159-162. PMID 2469530 DOI: 10.1139/Y89-026 |
0.47 |
|
| 1988 |
Samanen J, Brandeis E, Narindray D, Adams W, Cash T, Yellin T, Regoli D. The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists. Journal of Medicinal Chemistry. 31: 737-41. PMID 3351849 DOI: 10.1021/JM00399A008 |
0.307 |
|
| 1988 |
Rhaleb NE, Dion S, D'Orléans-Juste P, Drapeau G, Regoli D, Browne RG. Bradykinin antagonism: differentiation between peptide antagonists and antiinflammatory agents. European Journal of Pharmacology. 151: 275-9. PMID 2901970 DOI: 10.1016/0014-2999(88)90808-4 |
0.43 |
|
| 1988 |
Devillier P, Advenier C, Drapeau G, Marsac J, Regoli D. Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin-induced contractions of guinea-pig isolated trachea. British Journal of Pharmacology. 94: 675-84. PMID 2460177 DOI: 10.1111/J.1476-5381.1988.Tb11575.X |
0.427 |
|
| 1988 |
Giuliani S, Maggi CA, Regoli D, Drapeau G, Rovero P, Meli A. NK-1 receptors mediate the tachykinin stimulation of salivary secretion: selective agonists provide further evidence. European Journal of Pharmacology. 150: 377-9. PMID 2458268 DOI: 10.1016/0014-2999(88)90022-2 |
0.504 |
|
| 1988 |
Devillier P, Renoux M, Drapeau G, Regoli D. Histamine release from rat peritoneal mast cells by kinin antagonists. European Journal of Pharmacology. 149: 137-40. PMID 2456220 DOI: 10.1016/0014-2999(88)90051-9 |
0.537 |
|
| 1988 |
Dion S, Corcos J, Carmel M, Drapeau G, Regoli D. Substance P and neurokinins as stimulants of the human isolated urinary bladder. Neuropeptides. 11: 83-7. PMID 2452993 DOI: 10.1016/0143-4179(88)90015-7 |
0.543 |
|
| 1988 |
Regoli D. Peptide receptors in the airways. The American Review of Respiratory Disease. 136: S35-9. PMID 2446539 DOI: 10.1164/Ajrccm/136.6_Pt_2.S35 |
0.578 |
|
| 1988 |
Regoli D, D'Oleans-Juste P, Dion S, Rhaleb N-, Rouissi N, Drapeau G. Neurokinin selective agonists. Discovery and pharmacologic applications Regulatory Peptides. 22: 153. DOI: 10.1016/0167-0115(88)90373-4 |
0.364 |
|
| 1988 |
Parlani M, Astolfi M, Maggi CA, Rovero P, Abelli L, Regoli D, Meli A. Tachykinin receptors in the rat lower urinary tract Regulatory Peptides. 22: 141. DOI: 10.1016/0167-0115(88)90361-8 |
0.459 |
|
| 1988 |
Naline E, Advenier C, Devillier P, Drapeau G, Dion S, Regoli D. Characterization of neurokinin effects and receptors in human isolated bronchi Regulatory Peptides. 22: 133. DOI: 10.1016/0167-0115(88)90353-9 |
0.467 |
|
| 1988 |
Lew R, Burcher E, Regoli D. [125I]-Bolton-Hunter [Sar9, Met(O2)11]-substance P, a new selective radioligand reveals two subclasses of the NK1 receptor in rat brain and salivary gland Regulatory Peptides. 22: 113. DOI: 10.1016/0167-0115(88)90333-3 |
0.307 |
|
| 1988 |
Abelli L, Somma V, Maggi C, Regoli D, Rovero P, Meli A. Effect of intravenous tachykinins and tachykinin -related peptides on vascular permeability in the rat lower urinary tract Regulatory Peptides. 22: 27. DOI: 10.1016/0167-0115(88)90247-9 |
0.349 |
|
| 1987 |
Gulati N, Mathison R, Huggel H, Regoli D, Bény JL. Effects of neurokinins on the isolated pig coronary artery. European Journal of Pharmacology. 137: 149-54. PMID 3609137 DOI: 10.1016/0014-2999(87)90215-9 |
0.384 |
|
| 1987 |
Mastrangelo D, Mathison R, Huggel HJ, Dion S, D'Orléans-Juste P, Rhaleb NE, Drapeau G, Rovero P, Regoli D. The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. European Journal of Pharmacology. 134: 321-6. PMID 3471518 DOI: 10.1016/0014-2999(87)90363-3 |
0.391 |
|
| 1987 |
Dion S, Drapeau G, Rhaleb NE, D'Orléans-Juste P, Regoli D. Receptors for substance P and neurokinins. Correlation between binding and biological activities. European Journal of Pharmacology. 138: 125-8. PMID 3040425 DOI: 10.1016/0014-2999(87)90347-5 |
0.375 |
|
| 1987 |
Maggi CA, Giuliani S, Santicioli P, Regoli D, Meli A. Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors. Journal of Autonomic Pharmacology. 7: 11-32. PMID 3038917 DOI: 10.1111/J.1474-8673.1987.Tb00130.X |
0.528 |
|
| 1987 |
Drapeau G, d'Orléans-Juste P, Dion S, Rhaleb NE, Regoli D. Specific agonists for neurokinin B receptors. European Journal of Pharmacology. 136: 401-3. PMID 3038572 DOI: 10.1016/0014-2999(87)90313-X |
0.584 |
|
| 1987 |
Advenier C, Naline E, Drapeau G, Regoli D. Relative potencies of neurokinins in guinea pig trachea and human bronchus. European Journal of Pharmacology. 139: 133-7. PMID 2888665 DOI: 10.1016/0014-2999(87)90244-5 |
0.492 |
|
| 1987 |
Tousignant C, Dion S, Drapeau G, Regoli D. Characterization of pre- and postjunctional receptors for neurokinins and kinins in the rat vas deferens. Neuropeptides. 9: 333-43. PMID 2886949 DOI: 10.1016/0143-4179(87)90007-2 |
0.544 |
|
| 1987 |
Regoli D. Kinins, receptors, antagonists. Advances in Experimental Medicine and Biology. 549-58. PMID 2880480 DOI: 10.1007/978-1-4684-5143-6_73 |
0.546 |
|
| 1987 |
Dion S, D'Orléans-Juste P, Drapeau G, Rhaleb NE, Rouissi N, Tousignant C, Regoli D. Characterization of neurokinin receptors in various isolated organs by the use of selective agonists. Life Sciences. 41: 2269-78. PMID 2824947 DOI: 10.1016/0024-3205(87)90538-8 |
0.523 |
|
| 1987 |
Ploux O, Lavielle S, Chassaing G, Julien S, Marquet A, d'Orléans-Juste P, Dion S, Regoli D, Beaujouan JC, Bergström L. Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B Proceedings of the National Academy of Sciences of the United States of America. 84: 8095-8099. PMID 2446317 DOI: 10.1073/Pnas.84.22.8095 |
0.546 |
|
| 1987 |
Couraud JY, Frobert Y, Conrath M, Renzi D, Grassi J, Drapeau G, Regoli D, Pradelles P. Monoclonal antibodies to substance P: production, characterization of their fine specificities, and use in immunocytochemistry. Journal of Neurochemistry. 49: 1708-19. PMID 2445914 DOI: 10.1111/J.1471-4159.1987.Tb02428.X |
0.309 |
|
| 1987 |
Drapeau G, D'Orléans-Juste P, Dion S, Rhaleb N-, Rouissi N-, Regoli D. Selective agonists for substance P and neurokinin receptors. Neuropeptides. 10: 43-54. PMID 2444902 DOI: 10.1016/0143-4179(87)90088-6 |
0.522 |
|
| 1987 |
Maggi CA, Giuliani S, Santicioli P, Abelli L, Regoli D, Meli A. Further studies on the mechanisms of the tachykinin-induced activation of micturition reflex in rats: evidence for the involvement of the capsaicin-sensitive bladder mechanoreceptors. European Journal of Pharmacology. 136: 189-205. PMID 2439357 DOI: 10.1016/0014-2999(87)90711-4 |
0.421 |
|
| 1987 |
Couture R, Gupta A, Kérouac R, Escher E, Regoli D. Spinal actions of substance P analogues on cardiovascular responses in the rat: a structure-activity analysis. Canadian Journal of Physiology and Pharmacology. 65: 412-8. PMID 2438022 DOI: 10.1139/Y87-069 |
0.307 |
|
| 1987 |
Roch-Arveiller M, Regoli D, Chanaud B, Lenoir M, Muntaner O, Stralzko S, Giroud JP. Tachykinins: effects on motility and metabolism of rat polymorphonuclear leucocytes. Pharmacology. 33: 266-73. PMID 2432625 DOI: 10.1159/000138225 |
0.413 |
|
| 1987 |
Regoli D, Drapeau G, Dion S, D'Orléans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sciences. 40: 109-17. PMID 2432376 DOI: 10.1016/0024-3205(87)90349-3 |
0.526 |
|
| 1986 |
Regoli D, Drapeau G, Rovero P, Dion S, Rhaleb NE, Barabé J, D'Orléans-Juste P, Ward P. Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels. European Journal of Pharmacology. 127: 219-24. PMID 2875891 DOI: 10.1016/0014-2999(86)90367-5 |
0.572 |
|
| 1986 |
Regoli D, Drapeau G, Rovero P, Dion S, D'Orléans-Juste P, Barabé J. The actions of kinin antagonists on B1 and B2 receptor systems. European Journal of Pharmacology. 123: 61-5. PMID 2872074 DOI: 10.1016/0014-2999(86)90687-4 |
0.489 |
|
| 1986 |
D'Orléans-Juste P, Dion S, Drapeau G, Regoli D. Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins. European Journal of Pharmacology. 125: 37-44. PMID 2426129 DOI: 10.1016/0014-2999(86)90081-6 |
0.455 |
|
| 1986 |
Devillier P, Regoli D, Asseraf A, Descours B, Marsac J, Renoux M. Histamine release and local responses of rat and human skin to substance P and other mammalian tachykinins. Pharmacology. 32: 340-7. PMID 2425383 DOI: 10.1159/000138190 |
0.34 |
|
| 1986 |
Mizrahi J, Dion S, D'Orléans-Juste P, Escher E, Drapeau G, Regoli D. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists. European Journal of Pharmacology. 118: 25-36. PMID 2417867 DOI: 10.1016/0014-2999(85)90659-4 |
0.5 |
|
| 1986 |
Devillier P, Renoux M, Giroud JP, Regoli D. Peptides and histamine release from rat peritoneal mast cells. European Journal of Pharmacology. 117: 89-96. PMID 2417864 DOI: 10.1016/0014-2999(85)90475-3 |
0.47 |
|
| 1986 |
THEODOROPOULOS D, POULOS C, GATOS D, CORDOPATIS P, ESCHER E, MIZRAHI J, REGOLI D, DALIETOS D, FURST A, LEE TD. ChemInform Abstract: Conformationally Restricted C-Terminal Peptides of Substance P. Chemischer Informationsdienst. 17. DOI: 10.1002/Chin.198606292 |
0.301 |
|
| 1985 |
Escher E, D'Orléans-Juste P, Dion S, Drapeau G, Mizrahi J, Regoli D. A substance P antagonist not containing D-tryptophan. European Journal of Pharmacology. 105: 375-7. PMID 6210204 DOI: 10.1016/0014-2999(84)90636-8 |
0.315 |
|
| 1985 |
D'Orléans-Juste P, Dion S, Mizrahi J, Regoli D. Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. European Journal of Pharmacology. 114: 9-21. PMID 3930267 DOI: 10.1016/0014-2999(85)90515-1 |
0.415 |
|
| 1985 |
Regoli D, Mizrahi J, D'Orléans-Juste P, Dion S, Drapeau G, Escher E. Substance P antagonists showing some selectivity for different receptor types. European Journal of Pharmacology. 109: 121-5. PMID 2581793 DOI: 10.1016/0014-2999(85)90548-5 |
0.444 |
|
| 1985 |
Theodoropoulos D, Poulos C, Gatos D, Cordopatis P, Escher E, Mizrahi J, Regoli D, Dalietos D, Furst A, Lee TD. Conformationally restricted C-terminal peptides of substance P. Synthesis, mass spectral analysis and pharmacological properties. Journal of Medicinal Chemistry. 28: 1536-9. PMID 2413208 DOI: 10.1021/Jm00148A029 |
0.341 |
|
| 1985 |
Mathison R, Escher E, Huggel H, Mizrahi J, Regoli D. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues. European Journal of Pharmacology. 114: 147-55. PMID 2412854 DOI: 10.1016/0014-2999(85)90622-3 |
0.508 |
|
| 1985 |
Maggi CA, Giuliani S, Santicioli P, Regoli D, Meli A. Comparison of the effects of substance P and substance K on blood pressure, salivation and urinary bladder motility in urethane-anaesthetized rats. European Journal of Pharmacology. 113: 291-4. PMID 2412844 DOI: 10.1016/0014-2999(85)90750-2 |
0.328 |
|
| 1985 |
Mizrahi J, Dion S, D'Orléans-Juste P, Regoli D. Activities and antagonism of bombesin on urinary smooth muscles. European Journal of Pharmacology. 111: 339-45. PMID 2410284 DOI: 10.1016/0014-2999(85)90640-5 |
0.417 |
|
| 1984 |
Regoli D. Neurohumoral regulation of precapillary vessels: the kallikrein-kinin system. Journal of Cardiovascular Pharmacology. S401-12. PMID 6206349 DOI: 10.1097/00005344-198406002-00015 |
0.375 |
|
| 1984 |
Mizrahi J, Escher E, D'Orléans-Juste P, Regoli D. Undeca- and octa-peptide antagonists for substance P, a study on the guinea pig trachea. European Journal of Pharmacology. 99: 193-202. PMID 6203766 DOI: 10.1016/0014-2999(84)90241-3 |
0.526 |
|
| 1984 |
Regoli D, Escher E, Mizrahi J. Substance P--structure-activity studies and the development of antagonists. Pharmacology. 28: 301-20. PMID 6203130 DOI: 10.1159/000137979 |
0.485 |
|
| 1984 |
Mizrahi J, D'Orléans-Juste P, Drapeau G, Escher E, Regoli D. Partial agonists and antagonists for substance P. European Journal of Pharmacology. 98: 457-8. PMID 6202534 DOI: 10.1016/0014-2999(84)90301-7 |
0.407 |
|
| 1984 |
Regoli D, Escher E, Drapeau G, D'Orléans-Juste P, Mizrahi J. Receptors for substance P. III. Classification by competitive antagonists. European Journal of Pharmacology. 97: 179-89. PMID 6200337 DOI: 10.1016/0014-2999(84)90449-7 |
0.458 |
|
| 1984 |
Regoli D, Mizrahi J, D'Orléans-Juste P, Escher E. Receptors for substance P. II. Classification by agonist fragments and homologues. European Journal of Pharmacology. 97: 171-7. PMID 6200336 DOI: 10.1016/0014-2999(84)90448-5 |
0.408 |
|
| 1984 |
Regoli D, D'Orléans-Juste P, Escher E, Mizrahi J. Receptors for substance P. I. The pharmacological preparations. European Journal of Pharmacology. 97: 161-70. PMID 6200335 DOI: 10.1016/0014-2999(84)90447-3 |
0.381 |
|
| 1984 |
Barabé J, Caranikas S, D'Orléans-Juste P, Regoli D. New agonist and antagonist analogues of bradykinin. Canadian Journal of Physiology and Pharmacology. 62: 627-9. PMID 6146395 DOI: 10.1139/Y84-101 |
0.564 |
|
| 1983 |
Regoli D, Mizrahi J, D'Orléans-Juste P, Caranikas S. Effects of kinins on isolated blood vessels. Role of endothelium. Canadian Journal of Physiology and Pharmacology. 60: 1580-3. PMID 7165854 DOI: 10.1139/Y82-234 |
0.324 |
|
| 1983 |
Mizrahi J, D'Orléans-Juste P, Caranikas S, Regoli D. Effects of peptides and amines on isolated guinea pig tracheae as influenced by inhibitors of the metabolism of arachidonic acid. Pharmacology. 25: 320-6. PMID 7156180 DOI: 10.1159/000137758 |
0.361 |
|
| 1983 |
Mizrahi J, D'Orléans-Juste P, Drapeau G, Escher E, Regoli D. Partial agonists and antagonists for substance P. European Journal of Pharmacology. 91: 139-40. PMID 6193969 DOI: 10.1016/0014-2999(83)90376-X |
0.407 |
|
| 1983 |
Escher E, Couture R, Poulos C, Pinas N, Mizrahi J, Theodoropoulos D, Regoli D. Structure-activity studies on the C-terminal amide of substance P. Journal of Medicinal Chemistry. 25: 1317-21. PMID 6183431 DOI: 10.1002/Chin.198317341 |
0.3 |
|
| 1983 |
Caranikas S, Mizrahi J, Escher E, Regoli D. Synthesis and biological activities of substance P antagonists. Journal of Medicinal Chemistry. 25: 1313-6. PMID 6183430 DOI: 10.1002/Chin.198317317 |
0.368 |
|
| 1983 |
Roch-Arveiller M, Caranikas S, Regoli D, Giroud JP. Effects of bradykinin and some of its fragments on smooth muscles and chemotaxis. European Journal of Pharmacology. 88: 99-103. PMID 6133767 DOI: 10.1016/0014-2999(83)90396-5 |
0.485 |
|
| 1983 |
Barabé J, Babiuk C, Regoli D. Binding of [3H]des-Arg9-BK to rabbit anterior mesenteric vein. Canadian Journal of Physiology and Pharmacology. 60: 1551-5. PMID 6131738 DOI: 10.1139/Y82-229 |
0.355 |
|
| 1982 |
Dive V, Lintner K, Fermandjian S, St Pierre S, Regoli D. Preferred solution conformation of des-Arg9-bradykinin and analysis of structure-conformation-activity relationships in the series [Alan]des-Arg9-bradykinin. European Journal of Biochemistry. 123: 179-90. PMID 7067697 DOI: 10.1111/J.1432-1033.1982.Tb06515.X |
0.323 |
|
| 1982 |
Mizrahi J, Escher E, Caranikas S, D'orléans-Juste P, Regoli D. Substance P antagonists active in vitro and in vivo. European Journal of Pharmacology. 82: 101-5. PMID 6182006 DOI: 10.1016/0014-2999(82)90561-1 |
0.409 |
|
| 1982 |
Mizrahi J, Couture R, Caranikas S, Regoli D. Pharmacological effects of peptides on tracheal smooth muscle. Pharmacology. 25: 39-50. PMID 6181532 DOI: 10.1159/000137722 |
0.39 |
|
| 1982 |
Couture R, Mizrahi J, Caranikas S, Regoli D. Acute effects of peptides on the rat colon. Pharmacology. 24: 230-42. PMID 6178120 DOI: 10.1159/000137601 |
0.477 |
|
| 1982 |
Fournier A, Couture R, Regoli D, Gendreau M, St-Pierre S. Synthesis of peptides by the solid-phase method. 7. Substance P and analogues. Journal of Medicinal Chemistry. 25: 64-8. PMID 6177855 DOI: 10.1021/Jm00343A012 |
0.368 |
|
| 1982 |
Escher E, Couture R, Champagne G, Mizrahi J, Regoli D. Synthesis and biological activities of photoaffinity labeling analogues of substance P. Journal of Medicinal Chemistry. 25: 470-5. PMID 6175752 DOI: 10.1002/Chin.198235301 |
0.41 |
|
| 1982 |
Caranikas S, Mizrahi J, D'Orléans-Juste P, Regoli D. Antagonists of substance P. European Journal of Pharmacology. 77: 205-6. PMID 6174355 DOI: 10.1016/0014-2999(82)90023-1 |
0.333 |
|
| 1982 |
Couture R, Mizrahi J, Regoli D, Devroede G. Peptides and the human colon: an in vitro pharmacological study. Canadian Journal of Physiology and Pharmacology. 59: 957-64. PMID 6170411 DOI: 10.1139/Y81-146 |
0.481 |
|
| 1982 |
Marceau F, Knap M, Regoli D. Pharmacological characterization of the vascular permeability enhancing effects of kinins in the rabbit skin. Canadian Journal of Physiology and Pharmacology. 59: 921-6. PMID 6170409 DOI: 10.1139/Y81-142 |
0.526 |
|
| 1982 |
Babiuk C, Marceau F, St-Pierre S, Regoli D. Kininases and vascular responses to kinins. European Journal of Pharmacology. 78: 167-74. PMID 6122586 DOI: 10.1016/0014-2999(82)90233-3 |
0.451 |
|
| 1982 |
Stahl KW, Roch-Arveiller M, Regoli D, Giroud JP. Receptors for bradykinin in murine peritoneal macrophages: modulation of short-term spreading. Agents and Actions. 11: 624-7. PMID 6122356 DOI: 10.1007/Bf01978768 |
0.444 |
|
| 1982 |
Roch-Arveiller M, Regoli D, Giroud JP. Effects of bradykinin and various synthetic analogs on rat polymorphonuclear chemotaxis. Agents and Actions. 11: 499-502. PMID 6121475 DOI: 10.1007/Bf02004712 |
0.473 |
|
| 1982 |
Escher E, Laczkó E, Guillemette G, Regoli D. Biological activities of photoaffinity labeling analogues of kinins and their irreversible effects on kinin receptors. Journal of Medicinal Chemistry. 24: 1409-13. PMID 6118437 DOI: 10.1002/Chin.198221327 |
0.532 |
|
| 1982 |
Regoli D. Vascular receptors for polypeptides Trends in Pharmacological Sciences. 3: 286-288. DOI: 10.1016/0165-6147(82)91138-5 |
0.466 |
|
| 1982 |
ESCHER E, LACZKO E, GUILLEMETTE G, REGOLI D. ChemInform Abstract: BIOLOGICAL ACTIVITIES OF PHOTOAFFINITY LABELING ANALOGS OF KININS AND THEIR IRREVERSIBLE EFFECTS ON KININ RECEPTORS Chemischer Informationsdienst. 13. DOI: 10.1002/CHIN.198221327 |
0.372 |
|
| 1981 |
Quirion R, Regoli D, Rioux F, St-Pierre S. Structure-activity studies with neurotensin: analysis of positions 9, 10 and 11. British Journal of Pharmacology. 69: 689-92. PMID 7437646 DOI: 10.1111/J.1476-5381.1980.Tb07923.X |
0.441 |
|
| 1981 |
St-Pierre S, Lalonde JM, Gendreau M, Quirion R, Regoli D, Rioux F. Synthesis of peptides by the solid-phase method. 6. Neurotensin, fragments, and analogues. Journal of Medicinal Chemistry. 24: 370-6. PMID 7265123 DOI: 10.1002/Chin.198134331 |
0.329 |
|
| 1981 |
Gaudreau P, Barabé J, St-Pierre S, Regoli D. Structure-activity study of kinins in vascular smooth muscles. Canadian Journal of Physiology and Pharmacology. 59: 380-9. PMID 7237255 DOI: 10.1139/Y81-060 |
0.437 |
|
| 1981 |
Rioux F, Quirion R, St-Pierre S, Regoli D, Jolicoeur FB, Bélanger F, Barbeau A. The hypotensive effect of centrally administered neutrotensin in rats European Journal of Pharmacology. 69: 241-247. PMID 7215426 DOI: 10.1016/0014-2999(81)90469-6 |
0.314 |
|
| 1981 |
Gaudreau P, Barabé J, St-Pierre S, Regoli D. Pharmacological studies of kinins in venous smooth muscles. Canadian Journal of Physiology and Pharmacology. 59: 371-9. PMID 7016274 DOI: 10.1139/Y81-059 |
0.51 |
|
| 1981 |
Couture R, Gaudreau P, St-Pierre S, Regoli D. The dog common carotid artery: a sensitive bioassay for studying vasodilator effects of substance P and of kinins. Canadian Journal of Physiology and Pharmacology. 58: 1234-44. PMID 6162535 DOI: 10.1139/Y80-187 |
0.407 |
|
| 1981 |
Regoli DC, Marceau F, Lavigne J. Induction of beta 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide. European Journal of Pharmacology. 71: 105-15. PMID 6113153 DOI: 10.1016/0014-2999(81)90391-5 |
0.386 |
|
| 1981 |
Quirion R, Rioux F, Regoli D, St-Pierre S. Compound 48/80 inhibits neurotensin-induced hypotension in rats. Life Sciences. 27: 1889-95. PMID 6110157 DOI: 10.1016/0024-3205(80)90435-X |
0.362 |
|
| 1980 |
Escher E, Guillemette G, Leukart O, Regoli D. Pharmacological properties of two analogues of angiotensin II containing carboranylalanine (Car). European Journal of Pharmacology. 66: 267-72. PMID 7418720 DOI: 10.1016/0014-2999(80)90458-6 |
0.434 |
|
| 1980 |
Quirion R, Rioux F, Regoli D, St-Pierre S. Pharmacological studies of neurotensin, several fragments and analogous in the isolated perfused rat heart. European Journal of Pharmacology. 66: 257-66. PMID 7418719 DOI: 10.1016/0014-2999(80)90457-4 |
0.408 |
|
| 1980 |
Couture R, Regoli D. Vascular reactivity to angiotensin and noradrenaline in rats. Effect of aging and of uninephrectomy. Clinical and Experimental Hypertension. 2: 1-24. PMID 7418537 DOI: 10.3109/10641968009038549 |
0.314 |
|
| 1980 |
Rioux F, Quirion R, Leblanc MA, Regoli D, St-Pierre S. Possible interactions between neurotensin and prostaglandins in the isolated rat portal vein. Life Sciences. 27: 259-67. PMID 7401935 DOI: 10.1016/0024-3205(80)90146-0 |
0.436 |
|
| 1980 |
Quirion R, Rioux F, Regoli D, St-Pierre S. Selective blockade of neurotensin-induced coronary vessel constriction in perfused rat hearts by a neurotensin analogue. European Journal of Pharmacology. 61: 309-12. PMID 7363941 DOI: 10.1016/0014-2999(80)90133-8 |
0.415 |
|
| 1980 |
Quirion R, Regoli D, Rioux F, St-Pierre S. The stimulatory effects of neurotensin and related peptides in rat stomach strips and guinea-pig atria. British Journal of Pharmacology. 68: 83-91. PMID 7357202 DOI: 10.1111/J.1476-5381.1980.Tb10702.X |
0.302 |
|
| 1980 |
Rioux F, Quirion R, Regoli D, Leblanc MA, St-Pierre S. Pharmacological characterization of neurotensin receptors in the rat isolated portal vein using analogues and fragments of neurotensin. European Journal of Pharmacology. 66: 273-9. PMID 6252013 DOI: 10.1016/0014-2999(80)90459-8 |
0.497 |
|
| 1980 |
Gagnon G, Regoli D, Rioux F. Studies on the mechanism of action of glucagon in strips of rabbit renal artery. British Journal of Pharmacology. 69: 389-96. PMID 6156733 DOI: 10.1111/J.1476-5381.1980.Tb07027.X |
0.315 |
|
| 1980 |
Fournier A, Couture R, Magnan J, Gendreau M, Regoli D, St-Pierre S. Synthesis of peptides by the solid-phase method. V. Substance P and analogs. Canadian Journal of Biochemistry. 58: 272-80. PMID 6155184 DOI: 10.1002/Chin.198228309 |
0.346 |
|
| 1980 |
Marceau F, Barabé J, St-Pierre S, Regoli D. Kinin receptors in experimental inflammation. Canadian Journal of Physiology and Pharmacology. 58: 536-42. PMID 6106529 DOI: 10.1139/Y80-088 |
0.544 |
|
| 1980 |
Couture R, Rioux F, Regoli D. Vascular reactivity to angiotensin and noradrenaline following nephrectomy in rats. Clinical and Experimental Hypertension. 1: 393-405. PMID 756375 DOI: 10.3109/10641967809068615 |
0.31 |
|
| 1980 |
Quirion R, Rioux F, St-Pierre S, Regoli D. Increased sensitivity to neurotensin in fasted rats. Life Sciences. 25: 1969-73. PMID 529995 DOI: 10.1016/0024-3205(79)90600-3 |
0.301 |
|
| 1980 |
Drouin JN, Gaudreau P, St-Pierre S, Regoli D. Biological activities of kinins modified at the N- or at the C-terminal end. Canadian Journal of Physiology and Pharmacology. 57: 1018-23. PMID 519533 DOI: 10.1139/Y79-152 |
0.507 |
|
| 1980 |
Regoli D. Receptors for angiotensin: a critical analysis. Canadian Journal of Physiology and Pharmacology. 57: 129-39. PMID 232670 DOI: 10.1139/Y79-020 |
0.473 |
|
| 1979 |
Lemaire S, Magnan J, Regoli D. Rat vas deferens: a specific bioassay for endogenous opioid peptides. British Journal of Pharmacology. 64: 327-9. PMID 719230 DOI: 10.1111/J.1476-5381.1978.Tb08653.X |
0.377 |
|
| 1979 |
Drouin JN, Gaudreau P, St-Pierre SA, Regoli D. Structure-activity studies of [des-Arg9]-bradykinin on the B1 receptor of the rabbit aorta. Canadian Journal of Physiology and Pharmacology. 57: 562-6. PMID 487264 DOI: 10.1139/Y79-085 |
0.53 |
|
| 1979 |
Magnan J, Regoli D, Quirion R, Lemaire S, St-Pierre S, Rioux F. Studies on the inhibitory action of somatostatin in the electrically stimulated rat vas deferens. European Journal of Pharmacology. 55: 347-54. PMID 467493 DOI: 10.1016/0014-2999(79)90108-0 |
0.358 |
|
| 1979 |
Quirion R, Regoli D, Rioux F, St-Pierre S. An analysis of the negative inotropic action of somatostatin. British Journal of Pharmacology. 66: 251-7. PMID 465878 DOI: 10.1111/J.1476-5381.1979.Tb13673.X |
0.317 |
|
| 1979 |
Drouin JN, St-Pierre SA, Regoli D. Receptors for bradykinin and kallidin. Canadian Journal of Physiology and Pharmacology. 57: 375-9. PMID 455136 DOI: 10.1139/Y79-056 |
0.564 |
|
| 1979 |
Barabé J, Marceau F, Thériault B, Drouin JN, Regoli D. Cardiovascular actions of kinins in the rabbit. Canadian Journal of Physiology and Pharmacology. 57: 78-91. PMID 427648 DOI: 10.1139/Y79-012 |
0.512 |
|
| 1979 |
Magnan J, Regoli D. Characterization of receptors for angiotensin in the rat vas deferens. Canadian Journal of Physiology and Pharmacology. 57: 417-23. PMID 222410 DOI: 10.1139/Y79-063 |
0.375 |
|
| 1979 |
Escher E, Nguyen TM, Regoli D. Photoaffinity labeling of the angiotensin II receptor; pharmacology of the labeling peptides in the dark. Canadian Journal of Physiology and Pharmacology. 56: 956-62. PMID 217511 DOI: 10.1139/Y78-152 |
0.33 |
|
| 1979 |
Lintner K, Fermandjian S, Regoli D. Conformational features of bradykinin. A circular dichroism study of some peptide fragments and structural analogues of bradykinin. Biochimie. 61: 87-92. PMID 35240 DOI: 10.1016/S0300-9084(79)80316-8 |
0.318 |
|
| 1979 |
Couture R, Drouin J-, Leukart O, Regoli D. Biological activities of kinins and substance P octapeptides (4–11) in which phenylalanine residues have been replaced with L-carboranylalanine Canadian Journal of Physiology and Pharmacology. 57: 1437-1442. DOI: 10.1139/Y79-212 |
0.467 |
|
| 1979 |
Couture R, Fournier A, Magnan J, St-Pierre S, Regoli D. Structure–activity studies on substance P Canadian Journal of Physiology and Pharmacology. 57: 1427-1436. DOI: 10.1139/Y79-211 |
0.401 |
|
| 1979 |
LEMAIRE S, BERUBE A, DEROME G, LEMAIRE I, MAGNAN J, REGOLI D, ST-PIERRE S. ChemInform Abstract: SYNTHESIS AND BIOLOGICAL ACTIVITY OF β-ENDORPHIN AND ANALOGS. ADDITIONAL EVIDENCE FOR MULTIPLE OPIATE RECEPTORS Chemischer Informationsdienst. 10. DOI: 10.1002/Chin.197919370 |
0.408 |
|
| 1978 |
Gagnon G, Regoli D, Rioux F. A new bioassay for glucagon. British Journal of Pharmacology. 64: 99-108. PMID 698487 DOI: 10.1111/J.1476-5381.1978.Tb08646.X |
0.304 |
|
| 1978 |
Regoli D, Marceau F, Barabé J. De novo formation of vascular receptors for bradykinin. Canadian Journal of Physiology and Pharmacology. 56: 674-7. PMID 688094 DOI: 10.1139/Y78-109 |
0.533 |
|
| 1978 |
Quirion R, Rioux F, Regoli D. Chronotropic and inotropic effects of neurotensin on spontaneously beating auricles. Canadian Journal of Physiology and Pharmacology. 56: 671-3. PMID 688093 DOI: 10.1139/Y78-108 |
0.333 |
|
| 1978 |
Bérubé A, Marceau F, Drouin JN, Rioux F, Regoli D. The rabbit mesenteric vein: a specific bioassay for substance P. Canadian Journal of Physiology and Pharmacology. 56: 603-9. PMID 688083 DOI: 10.1139/Y78-096 |
0.441 |
|
| 1978 |
Quirion R, Rioux F, Regoli D. Effects of arachidonic acid and indomethacin on the in vitro release of prostaglandins by aortic strips of spontaneously hypertensive rats. Canadian Journal of Physiology and Pharmacology. 56: 509-11. PMID 667726 DOI: 10.1139/Y78-076 |
0.311 |
|
| 1978 |
Brabé J, Drouin JN, Regoli D, Park WK. Receptors for bradykinin in intestinal and uterine smooth muscle. Canadian Journal of Physiology and Pharmacology. 55: 1270-85. PMID 597778 DOI: 10.1139/Y77-173 |
0.485 |
|
| 1978 |
Escher EH, Nguyen TM, Robert H, St-Pierre SA, Regoli DC. Photoaffinity labeling of the angiotensin II receptor. 1. Synthesis and biological activities of the labeling peptides. Journal of Medicinal Chemistry. 21: 860-4. PMID 214562 DOI: 10.1021/JM00207A004 |
0.326 |
|
| 1978 |
Lemaire S, Bérubé A, Derome G, Lemaire I, Magnan J, Regoli D, St Pierre S. Synthesis and biological activity of beta-endorphin and analogues. Additional evidence for multiple opiate receptors. Journal of Medicinal Chemistry. 21: 1232-5. PMID 214559 DOI: 10.1021/Jm00210A012 |
0.404 |
|
| 1977 |
Regoli D, Barabé J, Park WK. Receptors for bradykinin in rabbit aortae. Canadian Journal of Physiology and Pharmacology. 55: 855-67. PMID 902160 DOI: 10.1139/Y77-115 |
0.432 |
|
| 1977 |
Regoli D, Barabé J, Thériault B. Does indomethacin antagonize the effects of peptides and other agents on the coronary circulation of rabbit isolated hearts. Canadian Journal of Physiology and Pharmacology. 55: 307-10. PMID 871962 DOI: 10.1139/Y77-044 |
0.371 |
|
| 1976 |
Rioux F, Park WK, Regoli D. Characterization of angiotensin receptors in rabbit isolated atria. Canadian Journal of Physiology and Pharmacology. 54: 229-37. PMID 953853 DOI: 10.1139/Y76-035 |
0.415 |
|
| 1975 |
Forget G, Heisler S, Park WK, Sirois P, Gagnon D, Regoli D. Characterization of an angiotensin II-fluorescamine derivative. The Journal of Pharmacy and Pharmacology. 27: 491-6. PMID 239153 DOI: 10.1111/J.2042-7158.1975.Tb09490.X |
0.37 |
|
| 1974 |
Gagnon DJ, Gauthier R, Regoli D. Release of prostaglandins from the rabbit perfused kidney: effects of vasoconstrictors British Journal of Pharmacology. 50: 533-538. PMID 4374986 DOI: 10.1111/J.1476-5381.1974.Tb08588.X |
0.304 |
|
| 1973 |
Park WK, Regoli D, Rioux F. Characterization of angiotensin receptors in vascular and intestinal smooth muscles. British Journal of Pharmacology. 48: 288-301. PMID 4354800 DOI: 10.1111/J.1476-5381.1973.Tb06915.X |
0.411 |
|
| 1973 |
Rioux F, Park WK, Regoli D. I. Pharmacology of angiotensin antagonists. Canadian Journal of Physiology and Pharmacology. 51: 108-13. PMID 4348958 DOI: 10.1139/y73-014 |
0.364 |
|
| Show low-probability matches. |